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1 Einleitung und Zielsetzung 
Die Aufnahme von Arzneistoffen über die Haut wird schon seit langem durch 
bewährte Arzneiformen gewährleistet, wobei in den letzten Jahren kolloidale 
Trägersysteme immer mehr an Bedeutung gewonnen haben. Zu diesen 
Systemen zählen moderne Dermatika, wie Liposomen, Mikroemulsionen, 
Kubische Gele und Nanoemulsionen. 
Vorteile wie hohe chemische und physikalische Stabilität, ausreichende 
Arzneistoff-Ladungskapazität für lipophile sowie hydrophile Moleküle, eine 
kontrollierte Freisetzungsrate und die Möglichkeit zum „Drug Targeting“ machen 
diese neuen innovativen Systeme zu einem interessanten und viel 
versprechenden Forschungsschwerpunkt in der Pharmazeutischen 
Technologie. Von besonderer Bedeutung sind die rheologischen Eigenschaften 
kolloidaler Systeme, die z.B. von Konzentration, Temperatur, Teilchengröße, 
Teilchenform etc. abhängen. Weiters sind diese Trägersysteme meist durch 
einfache Herstellungsmethoden produzierbar und deswegen in der 
pharmazeutischen Industrie gern genutzt.  
Im Bereich der dermalen und transdermalen Anwendung findet der Einsatz 
kolloidaler Systeme auf Grund ihrer permeationsfördernden Eigenschaften 
großes Interesse. Kubische Gele, Mikroemulsionen und Nanoemulsionen 
bestehen aus Wasser, Öl und Tenside als auch Ko-Tenside. Meist werden Öle 
und Tenside verwendet, die als chemische Permeationsförderer agieren. Sie 
vermögen die Integrität des Stratum corneum, der physiologischen 
Hautbarriere, permanent zu zerstören und so den Eintritt von Xenobiotika jeder 
Art in die systemische Zirkulation zu ermöglichen. Jedoch limitiert die 
Zusammensetzung solcher Formulierungen oft das Einsatzgebiet. Viele der 
Trägersysteme enthalten hautirritative und toxische Inhaltsstoffe. 
Im Rahmen der vorliegenden Dissertation sollten Kubische Gele, 
Mikroemulsionen und Nanoemulsionen entwickelt werden, die in erster Linie 
aus Inhaltsstoffen hoher dermaler Verträglichkeit und geringer Toxizität 
bestehen und sich durch eine hohe Wirkstofffreisetzung auszeichnen.  
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Der erste Teil der Arbeit bestand darin den Einfluss unterschiedlich lipophiler, 
fluorierter Modelldrogen auf die Mikrostruktur eines kürzlich neu entwickelten 
kubischen Systems, das aus einer Mischung von Polyoxyethylen 
(5)cetyl/oleylether und Polyoxyethylen(10)cetyl/oleylether, Wasser und 
Paraffinöl besteht, zu untersuchen [1,2]. Rheologische Messungen bei 
unterschiedlichen Temperaturen, sowie Hautdiffusionsversuche und 
Stabilitätsuntersuchungen von darin eingearbeiteten Wirkstoffen wurden 
durchgeführt. 
Der zweite Teil beschäftige sich mit der Entwicklung besser hautverträglicher 
kolloidaler Trägersysteme, da Polyoxyethylen-Derivate  zu leichten 
Hautirritationen führen können. Mikroemulsionen aus unterschiedlich 
zusammengesetzten Soja-Lezithinen sollten an Hand von Phasendiagrammen 
entwickelt werden.  Eine hohe dermale Verträglichkeit und geringe Toxizität der 
Formulierungen standen im Vordergrund.  
Ziel war es, den Einfluss von Lipoid S100, S75 und S45 auf das kolloidale 
System und dessen physikalisch-chemische Eigenschaften festzustellen. 
Parameter wie Partikelgröße, Polydispersitäts Index (PDI) und Viskosität 
wurden gemessen und die Hautpermeation von Modelldrogen und deren 
chemische Stabilität in den Zubereitungen wurden erforscht. Da 
Phosphatidylcholin in der Literatur mit einer hohen Membranaffinität und folglich 
als Membranpermeationsförderer gehandelt wird, stellte sich die Frage, ob 
unterschiedliche Anteile an Phosphatidylcholin (PC), Phosphatidylethanolamin 
(PE) und Lysophosphatidylethanolamin (LPE) zu einer Änderung der kolloidalen 
Mikrostruktur der Mikroemulsionen führen würden [3]. Daher war es auch von 
Interesse, ob die unterschiedlichen Lezithinzusammensetzungen  einen 
Einfluss auf die Hautdiffusion der ausgesuchten Modelldrogen haben.  
Anschließend sollten die Systeme hinsichtlich der unterschiedlichen 
Ölkomponenten Ölsäure und Isopropylmyristat  in Bezug auf die Hautdiffusion 
getestet werden. In einem nächsten Schritt wurden die unterschiedlichen 
Formulierungen mittels unterschiedlicher NMR-Methoden charakterisiert, um 
eine eventuelle Korrelation zwischen den physikalisch-chemischen 
Eigenschaften, Arzneistoffselbstdiffusion und Hautpermeation aufzuzeigen. 
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Der dritte Teil der Arbeit beschäftigte sich mit der Entwicklung hautfreundlicher, 
physikalisch stabiler Nanoemulsionen unter Verwendung eines 
Hochdruckhomogenisators, basierend auf bestehenden Standardrezepturen. 
Als hautfreundliche Tenside wurden Soja-Lezithin, ausgewählte Zuckertenside 
oder Polysorbat 80 verwendet. Der Vorteil von Nanoemulsionen gegenüber 
Mikroemulsionen besteht in erster Linie im geringeren Tensidgehalt.  
Nach erfolgter physikalisch-chemischer Charakterisierung und anschließenden 
Stabilitätstests, sollte in einem weiteren Schritt die Oberfläche der Partikel 
positiv geladen werden.  Als kationisches Additiv wurde das physiologisch 
vorkommende, anti-inflammatorisch wirkende Phytosphingosin eingearbeitet. 
Ziel war es durch die positive Ladung eine erhöhte Arzneistoffpermeation von 
Modelldrogen zu bewirken, da in vorangegangenen Studien bewiesen      
wurde, dass positive öberflächenmodifizierte Nanoemulsionströpfchen 
Wirkstoffe besser durch die Haut transportieren können als negativ geladene 
Partikel [4, 5].  
Der letzte Teil der Arbeit beschäftigte sich mit den anti-inflammatorischen 
wirkenden Phytosphingosin und N-Palmitoylethanolamin und deren 
Bindungskapazität an liposomalen DPPC-Modellmembranen. Mit Micro-
Differential-Scanning-Calorimetry sollten Wechselwirkungen nachgewiesen 
werden, die sich durch Verschiebungen der charakteristischen thermischen 
Phasenübergänge des Modelllipids DPPC auszeichnen. 
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2 Introduction and Aim of the study 
During the last years drug transport via the dermal and transdermal route has 
been supported by approved dosage forms, whereas colloidal systems became 
more and more important. Examples for such systems are liposomes, 
microemulsions, cubic systems and nanoemulsions.  
Advantages, such as high chemical and physical stability, sufficient drug loading 
capacity, controlled release characteristics and the possibility of drug targeting 
favour colloidal carriers in the field of pharmaceutical technology. The 
rheological properties of these systems depending on concentration, 
temperature, particle size and shape are of particular importance. Moreover, the 
feasibility of scaling up production with simple methods of production and 
reasonable overall costs makes colloidal carriers interesting candidates in the 
pharmaceutical industry.  
Vehicles in the field of dermal and transdermal application are of great interest 
due to their potential permeation enhancing effect. Cubic gels, microemulsions 
and nanoemulsions consist of water, oil and surfactant as well as co-surfactant. 
Usually, oil and surfactants with potential of chemical enhancement were used. 
They are able to interrupt the physiological stratum corneum barrier and 
therefore to allow the permeation of xenobiotics in the systemic circulation. 
However, the ingredients of such formulations are limiting the field of 
application. Various components of carrier systems are often skin irritating and 
toxic. 
The purpose of the present work was to develop cubic systems, microemulsions 
and nanoemulsions having a high permeation rate of active agents using highly 
skin friendly and non-toxic ingredients.  
In the first part the influence of selected fluorinated drugs with different solubility 
on the microstructure of an already evaluated cubic gel system should be 
investigated. The cubic gel consisted of a mixture of polyoxyethylen(5) 
cetyl/oleylether and polyoxyethylen(10)cetyl/oleylether, water and  paraffin-oil 
[1,2]. Rheological measurements at different temperatures, in vitro standard 
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diffusion experiments as well as the chemical stability of the incorporated 
fluorinated drugs should be performed.  
The second part of the study focused on the developing of higher skin friendly 
colloidal drug delivery systems, due to the skin irritation potential of 
polyoxyethylen-derivatives. Microemulsions consisting of differently composed 
soybean lecithins should be evaluated by means of pseudo ternary phase 
diagrams. These systems should be characterised by high skin compatibility 
and non-toxicity. It was the aim to investigate the influence of Lipoid S100, 
Lipoid S75 and Lipoid S45 on one hand on the physicochemical properties of 
the colloidal systems like particle size, polydispersity index (PDI), viscosity and 
on the other hand on the skin permeation and chemical stability of the 
incorporated model drugs. In literature data phosphatidylcholine is discussed to 
have a strong ability to adsorb on biomembranes and to enhance biomembrane 
permeability [3]. Therefore, it was the question, whether different amounts of 
phosphatidylcholine (PC) molecules, phosphatidylethanolamine (PE) and 
lysophosphatidylethanolamine are able to improve physicochemical behaviours 
in order to increase skin permeation. Additionally, the influence of different oil 
components oleic acid and isopropyl myristate should be investigated on skin 
permeation. As next step the microstructure of the systems should be analysed 
by different multinuclear NMR-techniques, in order to find a correlation between 
skin diffusion, physicochemical properties and drug self-diffusion coefficients.  
The third part of the study focused on the investigation of highly skin compatible 
physically stable nanoemulsions using high pressure homogenisation, based on 
standard o/w nanoemulsions. Therefore skin friendly surfactants like soybean 
lecithins, selected sugar esters or polysorbate 80 were used, respectively. A 
major advantage of nanoemulsions compared to microemulsions is the low 
surfactant concentration. After physicochemical characterisation and stability 
studies it was the main objective to get a positive surface charge of the 
particles. Phytosphingosine, a physiological component served as cationic 
additive. In recent published reports an improved skin permeability of positively 
modified nanoemulsion particles was indicated compared to negatively charged 
Introduction and Aim of the study 11
 
[4, 5].  The objective was to enhance drug permeation of active agents across 
skin by phytosphingosine as cationic compound.  
In the last part the anti-inflammatory phytosphingosine and N-
palmitoylethanolamine were tested on their ability of binding or penetrating into 
the layers of active phospholipids used as model membranes. In DSC-studies 
interactions are indicated by changes in the characteristic phase transition 
temperature. 
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3 Background 
3.1 Skin 
3.1.1 Structure and morphology of the skin 
The skin is the outer barrier of living tissue of plant, animal and human. It is the 
largest organ of the integumentary system made up of multiple layers of 
epithelial tissues, and guards the underlying muscles, bones, ligaments and 
internal organs. Because it interfaces with the environment, skin plays a very 
important role in protecting the body against pathogens. Its other functions are 
insulation, temperature regulation, sensation and synthesis of vitamin D and the 
protection of vitamin B folates [6]. The skin consists of epidermis, dermis and 
subcutis as well as of the appendages like hair follicle, sebaceous and sweat 
glands.  
 
 
Figure 1: Skin layers: epidermis, dermis and subcutis, showing a hair follicle, sweat gland and 
sebaceous gland (http://www.sinnesphysiologie.de/hvsinne/haut/hautin.htm, access date: 
05.06) 
The epidermis consists of stratum basale, stratum spinosum, stratum 
garnulousm and stratum corneum. The keratinocytes are built in the stratum 
basale by cell differentiation and under different differentiation processes they 
are moving into the stratum corneum, the outermost layer. The stratum 
Stratum corneum
Epidermis
Dermis 
Subkutis 
Background 13
 
corneum (SC) controls absorption and is the final product of epidermal 
differentiation. It is a highly complex organised and extremely adaptable, 
biologically death, but dynamic 10-15 µm thick skin layer [7]. It is composed 
mainly of corneocytes, cells that are containing keratin, a protein that helps 
keep the skin hydrated by preventing water evaporation. The thickness of the 
stratum corneum varies according to the amount of protection and/or grip 
required by a region of the body. In generally it consists of 15–20 cell layers 
built on corneocytes and intercellular lipids and is a multi-layered brick and 
mortar like structure [8] (Figure 2). It consists of lipid bilayer with alternating 
hydrophilic and hydrophobic areas. This is an efficient barrier against chemicals 
that are insoluble in fat and against those, which are insoluble in water. The 
intercellular lipids consist of ceramides (30 %), free fatty acids (30 %) as well as 
cholesterol and cholesterol esters. Unlike all other biological membranes, those 
in the stratum corneum do not contain phospholipids. The most remarkable of 
all the ceramides is the ester-linked ω-hydroxyacids, the acylceramide [7]. This 
acylceramide is one of the principal carriers of linolic acid in the epidermis and 
acts as a “molecular rivet” in the intercellular lipid lamellae of the SC [9]. 
 
Figure 2: The multi-layered brick and mortar model of the stratum corneum [10] 
The high degree of order of the intercellular lipids is important for the barrier 
function of the stratum corneum. The SC-lipids are building lipid bilayers, which 
are between 4-5 nm thick. For the stability and barrier function of the SC not 
only the brick mortar model is deciding, but also the clamp structure of the 
corneocytes, the corneodesmosomes and the tight junctions [6]. Furthermore 
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the epidermis consists of melanocytes, sensory Merkel-cells, immunology active 
Langerhans-cells and lymphocytes beside a multiplicity of keratinocytes (90%).  
The dermis is tightly connected to the epidermis by a basement membrane, and 
harbours many nerve endings that provide the sense of touch and heat. It 
contains the hair follicles, sweat glands, sebaceous glands, apocrine glands 
and blood vessels. The blood vessels in the dermis provide nourishment and 
waste removal to its own cells. The dermis is about 0.1 to 0.5 cm thick and 
consist of collagenous fibres (70%), providing a scaffold of support and elastic 
connective tissue, providing elasticity [6]. 
The subcutis or hypodermis is directly underlying the dermis and is mainly 
composed of adipose tissue. Its physiological function includes insulation and 
storage of nutrients and mechanical protection.  
3.1.2 Mechanism of dermal drug delivery 
The high degree of order of the intercellular lipids is important for the barrier 
function of the stratum corneum. There are a number of routes possible by 
which a molecule can cross the stratum corneum (Figure 3):  
? Intercellular route  
? Transcellular route 
? Transappendage route either through sweat glands or hair follicle 
? Corneodesmosomale route 
 
According new cognitions the transcellular route seems to bee implausible, 
because of molecules have to penetrate alternating lipophilic and hydrophilic 
layers [7]. Moreover, it seems that small polar molecules are penetrating 
through the corneodesmosomale route considering the high number of 
corneodesmosoes pro corneocytes. Corneodesmosomes are molecular joints 
between cells consisting of transmembranproteins playing a major role for the 
cohesion of corneocytes [7].  
The intercellular pathway is possible for lipophilic/apolar molecules through 
lateral diffusion along the lipophilic hydrocarbon chains of the stratum corneum 
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lipids [8]. In recent years, the transappendage route has become interesting for 
research. It seems to play a more important role as so far assumed [11,12].  
 
 
Figure 3: transport routes across the stratum corneum according to new cognitions of the skin 
barrier structure 1: intercellular pathway; 2: transcellular pathway; 3: corneodesmosomale 
pathway (http://www.pharmazeutische-zeitung.de/index.php; access date: 09.2008) 
Moreover, the rate at which permeation occurs is largely dependent on the 
physicochemical characteristics of the penetrant, the concentration of permeant 
applied, the partition coefficient of the permeant between the SC and the 
vehicle as well as the diffusivity of the compound within the stratum corneum 
[6]. 
Drug diffusion across the stratum corneum obeys Fick`s first law (equation 1), 
where steady-state flux (J) is related to the diffusion coefficient (D) of the drug in 
the stratum corneum over a diffusional path length or membrane thickness (h), 
the partition coefficient (P) between the SC and the vehicle and the applied drug 
concentration (c0) which is assumed to be constant: 
 
The influence of solubility and partition coefficient of a drug on diffusion across 
the SC has been extensively studied. Molecules showing intermediate partition 
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coefficient (log Pocatonol/water of 1-3) have adequate solubility within the lipid 
domains of the SC to permit diffusion through these domains, whereas still 
having sufficient hydrophilic nature to allow partitioning into the viable tissues of 
the epidermis [13].  
3.1.3 Penetration enhancement 
Chemical penetration enhancers increase skin permeability by reversibly 
damaging or altering the physicochemical nature of the stratum corneum to 
reduce its diffusion resistance. Therefore, scientists are searching for 
possibilities to enhance drug permeation across skin since many years. The 
effectiveness of a permeation enhancer is mostly dependent on its 
physicochemical properties. These properties are responsible for the 
penetration route of the molecules across the SC, the polar or apolar pathway. 
The enhancer activity of many classes of chemicals has been tested including 
water, surfactants, essential oils and terpens, Azone analogues, dimethyl 
sulfoxide (DMSO), alcohols and fatty acids [13, 14]. On of the most researched 
compound is oleic acid, which is forming pools within the lipid domains to create 
permeable pores that provide less resistance for polar molecules [8, 13, 15]. On 
the other hand Azone appears to influence the permeation as well on the polar 
as on the apolar pathway due to its chemical structure [7]. In addition some 
chemicals have been identified as penetration retarders. To sum up the 
mechanism by which enhancers effect skin permeability are: 
? Disruption of the intercellular bilayer structure 
? Interaction with the intercellular proteins of the stratum corneum  
? Improvement of partitioning of a drug, co-enhancer, or co-solvent into the 
stratum corneum 
One of the problems associated with many chemical penetration enhancers is 
their irritation and toxicity potential. Therefore, the use for clinical applications is 
limited. In recent years there have been move towards investigations of 
potential enhancers classified as GRAS (Generally Regarded As Safe), such as 
essential oils and terpens, and polymeric enhancers [16].  
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Also a number of electrical methods of penetration enhancement have been 
evaluated. These include iontophoresis, phonophoresis, electroporation and 
photomechanical waves [13]. In addition synergy between chemical enhancers 
and electrically assisted methods have been described [17].  
Beside the penetration enhancement by stratum corneum modification the 
enhancement can also be improved by optimisation of drug and vehicle 
properties. Thereby drug selection, pro-drug & ion pairs, drug-vehicle 
interactions, chemical potential of drug, complexes, liposomes vesicles and 
particles are all different techniques to enhance drug permeation [13].  
An overview of techniques to optimise drug permeation across skin is given is 
given in Figure 4.  
 
 
Figure 4: Techniques to optimise drug permeation across the skin [13] 
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3.2 Colloidal drug delivery systems 
Colloidal carriers have attracted the main interest because they are promising 
systems for drug delivery across skin. The important requirements such as non-
toxicity, sufficient drug loading capacity, possibility of drug targeting, controlled 
release characteristics and chemical and physical storage stability can all be 
fulfilled by these systems [18]. The common characteristics of all colloidal 
systems are the submicron particle size. The carriers might differ in materials, 
composition, drug loading and application spectrum. But in the first place, 
nanosized carriers are treated as hopeful means to increase the solubility and 
therefore the bioavailability of poorly water-soluble active ingredients [19].  
 
3.2.1 Cubic gels 
Cubic “ringing” gels have an interesting thermodynamically stable structure 
consisting of curved bi-continuous lipid bilayer in three dimensions, separating 
two congruent networks of water channels (Figure 5). The water pore diameter 
of the fully swelled phase is about 5 nm and the phase is very viscous [20]. 
 
             
 
Figure 5: Cubic gel structures [20, 21] 
 
The unique structure of cubic phase has been extensively studied using various 
spectroscopic techniques and their resemblance to bio-membranes has 
prompted many scientists to study behaviour of active molecules in cubic 
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phases [2]. Cubic phases are structurally closely related to microemulsions and 
can be prepared at water concentrations from 55 to 85% with 15-45% of lipid, 
usually GMO (glyceryl monooleate). The diffusion of drugs from a cubic phase 
typically shows controlled release from such matrices as indicated by Higuchi`s 
square root of time release kinetics. Incorporation of a drug in a cubic phase 
can cause phase transformation to a lamellar or reversed hexagonal phase 
depending on the polarity and concentration of the drug, which may affect the 
release profile. Biodegradability, phase behaviour, ability to deliver drugs of 
varying sizes and polarity and the ability to enhance the chemical and/or 
physical stability of incorporated drugs and proteins make cubic phases 
excellent candidates for use as drug delivery vehicles [20, 22]. However, cubic 
gels have also disadvantages. One of the major is the extremely high viscosity 
of the formulation that may be limited to specific applications such as 
periodontal, mucosal, vaginal and short acting oral drug delivery. Beside, also 
the skin compatibility and toxicity of the ingredients should be taken into 
consideration. Therefore, a careful analysis of risks and benefits is necessary. 
 
3.2.2 Microemulsions 
Microemulsions are colloidal dispersions composed of an oil phase, aqueous 
phase, surfactant and co-surfactant at appropriate ratios [15]. They are 
generally defined as isotropic, transparent and thermodynamically stable liquids 
with ultra low interfacial tension, large interfacial area and the capacity to 
solubilize both aqueous and oil-soluble compounds [15, 23-25]. The essential 
distinction between normal emulsion and microemulsions is their particle size 
and stability. Usually the droplet diameter is within the range of 10 -100 nm [25]. 
The use of lower alkanols as co-surfactants (butanol, pentanol, hexanol) is 
necessary to produce transparent solutions comprising dispersions of either 
water in oil (w/o), oil in water (o/w) or bi-continuous structures (Figure 6).  
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Figure 6: Structures of microemulsions; a) o/w microemulsion; b) bi-continuous structure; c) w/o 
microemulsion [26] 
The co-surfactants lower the interfacial tension between oil and water 
sufficiently low for almost spontaneously formation of the system. The miscibility 
of oil, water and amphiphile (surfactant plus co-surfactant) depends on the 
overall composition, which is system specific. Ternary and quarterny phase 
diagrams (Figure 7) can describe the phase manifestations and are essential in 
the study of microemulsions [23, 24, 27, 28]. Such characteristics textures are 
commonly referred as Winsor phases and the classification is distinguished in a 
single phase region of common micelles or oil in water (o/w) microemulsions 
(Winsor I), a reverse micelle phase or water-in-oil (w/o) microemulsions (Winsor 
II), a middle microemulsion phase, so called bicontinuous phase (Winsor III) 
and a single phase with oil, water and surfactant homogeneously mixed (Winsor 
IV)[24].  
 
Figure 7: Schematic ternary phase diagram representing Winsor classification. L1 single phase 
region of normal micelles or o/w microemulsions; L2 reverse micelles or w/o microemulsions; D 
anisotropic lamellar liquid crystalline phase [24]  
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In the last years many reports are dealing with microemulsions and there 
pharmaceutical use [3, 29, 30]. Three main mechanisms have been proposed to 
explain the advantages of microemulsions for the dermal and transdermal use: 
? The high solubility potential for lipophilic and hydrophilic drugs, which 
might increase the thermodynamic activity towards the skin 
? Ingredients of microemulsions can act as permeation enhancers 
? Enhancing effect on dermal and transdermal ability over conventional 
formulation    
However, there are also several factors limiting the uses of microemulsions in 
the pharmaceutical and medicinal fields. Toxicity and bio-incompatibility of 
surfactants and co-surfactants and requirement of high concentrations of 
surfactant make the findings of skin friendly ingredients for microemulsions 
necessary. Therefore, the use of natural occurring surfactants was proposed 
such as soybean-lecithins and unsaturated fatty acid esters as oil component 
[3, 31, 32].  
 
3.2.3 Nanoemulsions 
Another interesting group of drug delivery vehicles are nanoemulsions. They 
are part of a broad class of multiphase colloidal dispersions. Although some 
lyotropic liquid crystalline phases, also known as micellar phases, mesophases 
and microemulsions may appear to be similar to nanoemulsions in composition 
and nanoscale structure, such matrices are actually quite different. 
Nanoemulsions do not form spontaneously, because an external shear has to 
be applied to rupture larger droplets into smaller ones [33]. They can be 
prepared by spontaneous emulsification such as phase inversion temperature 
(PIT) emulsification or phase inversion composition, or by using a high shear 
device [34]. Generally, nanoemulsions can be defined as oil in water emulsions 
with mean particle size diameters ranging from 20 to 200 nm [35]. The particles 
which are formed exhibit a liquid, lipophilic core separated from the surrounding 
aqueous phase by a monomolecular layer of phospholipids (Figure 8). Due to 
their lipophilic interior, nanoemulsions are more suitable for the transport of 
lipophilc compounds than liposomes. 
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Figure 8: Structure of nanoemulsion droplet (www.pharmoscorp.com/img/bd_fig2.jpg, access 
date: 11.2008)  
The attraction of nanoemulsions for application in health care as well as in 
cosmetics is due to the following advantages [37]: 
? The very small droplet size causes a large reduction in the gravity force 
and the Brownian motion may be sufficient for overcoming gravity. This 
means that no creaming or sedimentation occurs on storage. 
? Nanoemulsions are suitable for efficient delivery of active ingredients 
across the skin, especially for non polar active compounds. The large 
surface area of the emulsions system allows rapid penetration of actives.   
? Nanoemulsions can be prepared using reasonable surfactant 
concentrations. Usually a surfactant concentration of 5-10% may be 
sufficient, whereas microemulsions require a surfactant concentration of 
20 % and higher.  
? Nanoemulsions may be applied as a substitute for liposomes and 
vesicles, which are much less stable 
Although, nanoemulsions are proposed for numerous applications in pharmacy 
as drug delivery systems, one of the main problems is the Ostwald ripening, 
which is perhaps the most serious problem with nanoemulsions. This results 
from the difference in solubility between small and large particles [37-39]. 
Ostwald ripening can be overcame for example by addition of a second 
disperse phase component or by modification of the interfacial film at the o/w 
interface [37].  
Background 23
 
3.3 Investigated compounds  
The investigated compounds were chosen with regard to skin compatibility and 
toxicity. They are naturally occurring ingredients such as soybean-lecithins, 
phytosphingosine and N-palmitoylethanolamine and promising candidates for 
drug delivery systems. 
3.3.1 Soybean-Lecithins 
Lecithin is a naturally-occurring substance composed of phosphoric acid, 
choline, fatty acid, glycerol, glycolipids, triglycerides and phospholipids such as 
phosphatidylcholine, phosphatidylethanolamine, lysophosphatidylcholine and 
phosphatidylinositol.  They are occurring in animal and plant tissues and belong 
to the group of glycerophospholipids.  
In aqueous solution its phospholipids can form bilayer structures, micelles or 
lamellar structures, depending on hydration and temperature. Therefore 
lecithins are used as surfactants that are classified as amphiphile, due to their 
hydrophilic and lipophilic parts, which determine their surface active properties. 
The physiological impact is the enhancement of the skin barrier function and the 
stabilising effect of the natural transepidermal water loss [40]. Lecithins usually 
are non-irritating and non-sensitizing for animal and human skin [41]. Moreover 
lecithin compounds present an affinity to cellular membranes thus leading to an 
increased absorption of several drugs [31]. 
Soybean-lecithin is isolated from soy beans and the main phospholipids are 
phosphatidylcholine (50-90%), phosphatidylethanolamine (5-10%) 
phosphatidylinositol and phosphatidic acid (Figure 9).  
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Figure 9: Molecular structures of main phospholipids [42]  
For the investigated drug delivery systems of the present work different 
commercially available soybean-lecithins are used, namely Lipoid S100, Lipoid 
S75 and Lipoid S45. The lecithins exhibited different amounts of 
phosphatidylcholine (PC), lysophosphatidylcholine (LPC) and 
phosphatidylethanolamine (PE).  
 
Table 1: Compositions of the main components within the different soybean-
lecithins as supplied by the manufactory  
 
Lecithin PC LPC PE 
 % (w/w)b %(w/w)b  %(w/w)b  
Lipoid S100 98.00 0.70  < 0.1  
Lipoid S75     72.70 1.80  8.50  
Lipoid S45 48.80 1.60  15.40  
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3.3.2 Sugar surfactants 
Sugar surfactants are getting great interest because they display some 
properties that are different from traditional non-ionic surfactants of the alkyl 
ethoxylate type. In addition, the sugar-based surfactants are made from 
renewable raw materials (at least the polar part), they are easily biodegradable, 
and they are mild on skin. These positive properties have stimulated increased 
research, and it can predicted that these types of surfactants will be increasingly 
used in commercial products [43].  
Sucrose fatty acid esters (SE) are non-ionic surfactants consisting of sucrose as 
hydrophilic group and a fatty acid as liphophilic group (Figure 10). Usually the 
products are mixtures of 70-80% monoesters and 20-30% bi-, tri- and 
polyesters.  
                                       
Figure 10:  Chemical structure of sucrose monoester (R= fatty acid)  
They are available with a wide range of HLB (hydrophilic-lipophilic balance), 
controlled by the degree of esterification and the type of fatty acid used and 
exhibit good emulsifier capacity and therefore surfactant functionality [44, 45].  
Sucrose esters have the potential of inserting between the lipophilic tails with 
their long hydrocarbon chain allowing the sucrose ring to interact with the polar 
lipid head groups. The interaction with these groups can modify hydrogen 
bonds and ionic forces, distributing the hydration spheres of the lipids, thus 
resulting in alteration of the head group domain. Among the group of sucrose 
esters sucrose laureate is described to have the best enhancer activity [45].  
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3.3.3 Oleic acid  
Oleic acid, a monosaturated omega-9 fatty acid, belongs to the lipids that are 
naturally occurring in the stratum corneum (Figure 11) and is abundant in some 
vegetable oils (e.g., olive, palm, peanut, and sunflower seed) [40]. 
HO
O
H3C
 
Figure 11: Molecular structure of oleic acid (C18H34O2); molecular Mass: 282.4 g/mol  
Since a couple of years extensive investigations are made concerning the 
mechanism of action [8, 46-48]. It was found that oleic acid disrupts the 
structure of the bilayers by forming pools due to their cis double bond. It is likely 
that the cis double bond requires some considerable energy and therefore pool 
formation and phase separation is favoured [8].   
3.3.4 Isopropyl myristate 
Isopropyl myristate (IPM) is the ester of isopropanol and myristic acid and is 
often used in topical preparations as well as in the cosmetic field, where good 
absorption through the skin is desired (Figure 12).  
O
O
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Figure 12: Chemical structure of Isopropyl myrsistate (C17H34O2); Molecular Mass: 270.45 g/mol  
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Among the past years many studies were performed using IPM as penetration 
enhancer due to its well topical tolerability [15, 49]. Some researcher reported 
that IPM incorporation into SC results in densely packed bilayer lipids and a 
loss of order of the corneocyte-bonded lipids [50].  
Moreover IPM is an ideal emollient for skin softening. It can form a thin layer to 
maintain moisture, which additionally favourite IPM as a good ingredient in drug 
delivery systems.  
 
3.3.5 Phytosphingosine 
Phytosphingosine (PS), a free sphingoid base, is naturally present in the human 
body and is found in the stratum corneum (Figure13). It inhibits the growth of 
micro-organisms on the skin, reduces effectively the signs of acne and acts as 
natural anti-inflammatory agent. Because of these properties, PS is considered 
to be part of the skin’s natural defence system [51]. 
 
 
Figure 13: Chemical structure of phytosphingosine (C18H39NO3); molecular Mass: 317.15 g/mol 
At physiological skin pH, PS is protonated at the amino-group and influences 
the surface charges of the nanoparticles, as previously reported [5]. This 
indicates that PS is located at the oil/water interface and by protonating the 
amino-group the droplets became positive, which provides increased skin 
permeation [4, 5].  
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Figure 14: Design of a phytosphingosine positive charged nanoparticel [36] 
In summary, phytosphingosine seems to have a wide range of product 
applications and interesting physicochemical properties, which makes it an 
interesting candidate for topical use.  
3.3.6 N-Palmitoylethanolamine 
N-palmitoylethanolamine (PEA) is a naturally occurring C16:0 fatty acid 
derivative where the carboxylate function is amidated by the primary amine of 
ethanolamine (Figure15). It is found in the in the most mammalian tissue and is 
isolated from soybean lecithins and egg yolk [52].  
 
Figure 15: Structure of N-palmitoylethanolamine (C18H37NO2); molecular Mass: 299.49 g/mol 
Besides his interesting biological properties like inhibition of sperm fertilizing 
capacity and gap-junction conductance, PEA is also of considerable interest 
because of its properties as anti-inflammatory and anti-viral agent [53]. PEA is a 
endogenous ligand for cannabiniod receptors that are already found to be 
expressed in human skin [54]. Cannabinoid receptors bind endogenous 
Cannabinoids such as PEA and anti-analgetic effects can be achieved.  
Consequently, these findings make PEA an interesting candidate for topical 
delivery systems.  
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Abstract 
 
The purpose of the present study was to investigate the influence of different 
drugs exhibiting different solubility on the viscoelastic properties and on the skin 
diffusion profile of a ringing gel. In a preliminary rheology study with the placebo 
gel predominating elastic properties were confirmed and a temperature 
influence was indicated.  Fluconazole, fludrocortisone-acetate, flumethasone-
pivalate, flutamide and flufenamic-acid each 1% (w/w) were incorporated into 
the preparation and oscillatory measurements were performed at temperatures 
of 25°, 28°, 32° and 37 °C. In all drug containing formulations a high elastic G’ 
value predominated the viscous G’’ value. The highest G’ value could be 
obtained with the incorporated flumethasone-pivalate. Additionally in almost all 
cases the G’ values decreased with increasing temperature compared to the 
placebo gel.  
Additionally in vitro standard diffusion experiments using Franz-type cells and 
porcine skin were performed. Following rank order of the cumulative drug 
release after 48 hours was obtained: fluconazole > flufenamic-acid > 
flumethasone-pivalate > flutamide > fludrocortisone-acetate.  Furthermore an 
excellent chemical stability of all incorporated drugs was confirmed over 10 
weeks.  
 
 
Keywords: Fluconazole; Fludrocortisone-acetate; Flumethasone-pivalate; 
Flutamide; Flufenamic-acid; Skin permeation; Rheology; Chemical stability;  
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1. Introduction 
 
For topical treatment of dermatological diseases as well as for skin care a wide 
array of vehicles ranging from solids to semisolids and liquid preparations are 
available. A major advantage using various drugs over the dermal or 
transdermal way is to eliminate negative side effects caused by using chemical 
drugs on the peroral route. Within the semisolid preparations, the use of 
transparent gels has expanded both in pharmaceuticals and in cosmetics. One 
group of very interesting formulations are “cubic gels”, which might be 
structurally very closely related to microemulsions. Like microemulsions cubic 
gels are defined as a dispersion consisting of oil, surfactants, co-surfactants 
and aqueous phase, which are thermodynamically stable. Microemulsions and 
cubic gels have several advantages such as enhanced drug solubility, good 
thermodynamic stability, enhancing effect of transdermal ability over 
conventional formulations [1]. General forms are gels with a ringing behaviour. 
On one hand they are interesting because of their colloid–chemical structure, 
which is accessable only with physical-chemical experiments like Small Angle 
X-Ray Scattering or NMR- self diffusion experiments. On the other hand they 
are important as dermal drug delivery systems with optimal release 
characteristics and matrix behaviour. Recently a cubic gel has been 
characterised by NMR-self diffusion experiments and rheology [2]. In the 
present paper fluorinated drug candidates were selected, where it will be very 
easy in further studies to analyse the diffusion coefficients of the drugs with high 
sensitivity by F19 NMR studies. 
The aim of the study was to investigate the influence of different lipophilic drugs 
like fluconazole, fludrocortisone-acetate, flumethasone-pivalate, flutamide and 
flufenamic-acid on rheology parameters of this cubic gel. Furthermore in vitro 
skin permeation studies and chemical stability of these selected drugs will be 
analysed. 
 
 
 
 
Publications 32
 
2. Material and methods 
 
2.1. Materials 
 
Fluconazole (CAS: 86386-73-4), flufenamic-acid (CAS: 530-78-8), flutamide 
(CAS: 13311-84-7) and flumethasone-pivalate (CAS: 2002-29-1) were 
purchased from Kemprotec (UK). Fludrocortisone-acetate (CAS: 514-36-3) was 
purchased from Sigma-Aldrich (St.Louis, USA). Polyoxyethylene-5-
cetyloleylether and polyoxyethylene-10-cetyloleylether were kindly donated by 
Cognis (Düsseldorf, Ge). All other chemicals used were of analytical reagent 
grade and used as received without any further purification. 
 
2.2 Formulations 
 
The formulation was prepared by mixing 1.5 g of the surfactant mixture of 
polyoxyethylene-5-cetyloleylether and polyoxyethylene-10-cetyloleylether (1+1), 
2.75 g of water and 0.8 g of paraffin liquid as the oily component at 
temperatures up to 70-80°C. A clear semisolid stable very elastic “ringing” gel 
was formed [2]. 
The fluorinated drugs fluconazole, fludrocortisone-acetate, flumethasone-
pivalate, flutamide and flufenamic-acid (each 1% w/w) were incorporated into 
the systems. 
For the formulations with fluconazole, flutamide and flufenamic-acid transparent 
highly viscous formulations were built up. For fludrocortisone-acetate and 
flumethasone-pivalate a turbid but also highly viscous ringing gel formulation 
was built up. 
 
2.3 Rheological measurements 
 
Oscillatory shear experiments were performed on a Haake rheometer Rotovisco 
RT20 (Haake, Karlsruhe, Germany, thermo controller Haake F6/8). The 
rheometer tool was a thermostatically controlled tool with a 20-mm diameter 
plate/plate (PP20/Ti). The experiments were performed at four temperatures 
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25°, 28°, 32° and 37°C. The sample amount was between 0.5-1g. By this 
modus the induced response is measured (strain) when a sinusoidal stress is 
applied to the sample. After the identification of the linear viscoelastic region, 
samples were investigated over a frequency of 0.1 to 10 Hz. The parameters 
obtained were the complex modulus G* consisting of the elastic modulus G’ and 
the viscous modulus G’’, tan δ, and ω the angular velocity of oscillatory stress. 
According their correlations the parameters are calculated by: 
G’= G* cos (δ) 
G’’= G* sin (δ) 
tan δ = G’’/G’ 
       ω = 2πν 
The measurements were performed in triplicate. The values in the figures are 
the average values of three experiments. 
 
2.4 Solubility in the acceptor medium 
 
Of each drug the solubility in 0.012 M phosphate buffer (pH, 7.4) was analysed. 
Therefore an excess of each drug was added to the buffer and stirred by a 
magnetic bar for 24 hours at room temperature. Afterwards a filtration through a 
Minisart RC4 filter was performed and 20 µl of the filtration were injected into 
the HPLC system. 
The experiments were performed in triplicate.  
 
2.5 Skin preparation 
 
Porcine abdominal skin was shaved and then prepared with a dermatome (GB 
228R, Aesculap) set at 1.2 mm. The skin was stored in a freezer at -20°C until 
use. Two hours prior to the experiment the samples were thawed. 
 
2.6 Diffusion cell preparation 
 
Permeation studies for the investigated drugs were performed using Franz-type 
diffusion cells having a permeation area of about 1 cm². The receptor 
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compartment was filled with 2 ml of 0.012 M phosphate buffer (pH, 7.4). 
Excised skin was mounted in the cell, stratum corneum uppermost, with the 
dermal side facing the receptor compartment. The diffusion cells were 
thermostated at skin surface temperature of 32°C and stirred by magnetic bars. 
At defined time intervals 200 µl (2, 4, 6, 8, 24, 28, 32 and 48 h) were removed 
for analysis and replaced with fresh acceptor medium. Approximately 0.6 g of 
each formulation was applied. Three parallel experiments were performed for 
each formulation. 
 
2.7 Chemical stability 
 
From each drug containing gel formulation stability studies were performed. All 
formulations were stored in tubes under room temperature for 10 weeks. The 
drug amounts were analysed at the day of preparation (starting point) and 
afterwards weekly.  
About 10 mg of the formulation were dissolved in 1 ml of methanol and 
vigorously shaken for 60 min. Then the solution was centrifuged for 6 min 
(3000G) and afterwards 20 µl were injected into the HPLC system. 
 
2.8 HPLC analysis 
 
All samples were quantified for their drug content by HPLC (Perkin Elmer, US) 
consisting of an automatic auto sampler ISS-200, a pump and an UV-diode 
array detector. For all drugs the stationary phase was a Nucelosil 100 - 5C18 
column (240 mm x 4 mm; ARC-Seibersdorf Austria). 
At least 8 different standard solutions per drug in the mobile phase were 
prepared and calibrations curves were calculated on the basis of peak area 
measurements using standard samples. They were generated with a correlation 
coefficient between 1.0 and 0.9996 for all drugs. 
  
Fluconazole 
For the quantification of fluconazole we used a modified method described by 
Wang et al. (2003) [3]. The mobile phase consisted of 0.012 M phosphate buffer 
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(pH, 7.4) and methanol (55:45 v/v) and 1 mmol octanesulfonic-acid. The 
detection wavelength was 260 nm and the flow rate was 1.0 ml/min. The 
retention time was approx. 5.60 min. The concentration range of the standard 
solution for fluconazole was between 15.23 and 121.9 µg/ml. 
 
Fludrocortisone-acetate 
For the quantification of fludrocortisone-acetate the mobile phase consisted of 
acetonitrile and water (40:60 v/v) as described by Cisternino et al. (2003) [4]. 
The detection wavelength was set at 240 nm and the flow rate was 0.8 ml/min. 
The retention time was approx. 12.10 min. For fludrocortisone-acetate the 
concentration range of the standard solution was between 3.00 and 133.65 
µg/ml.  
 
Flumethasone-pivalate 
For the quantification of flumethasone-pivalate a previously reported method 
was used [5]. The mobile phase consisted of acetonitrile and water (40:60 v/v) 
and the detection wavelength was set at 240 nm. The flow rate was 1.0 ml/min 
and the retention time was approx. 6.20 min. The concentration range of the 
standard solution was between 0.92 and 103.63 µg/ml. 
 
Flutamide 
The mobile phase consisted of acetonitrile, methanol and water (30:25:45 v/v/v) 
and the detection wavelength was 300 nm as described by Leibinger [6]. The 
flow rate was set at 0.5 ml/min and the retention time was approx. 20.18 min. 
For flutamide the standard concentration range was between 1.53 and 96.24 
µg/ml. 
 
Flufenamic-acid 
For the quantification of flufenamic-acid the mobile phase consisted of 
methanol, water and glacial acid (80:20:1 v/v/v). The detection wavelength was 
set at 245 nm, the flow rate was 1.0 ml/min and the retention time was approx. 
6.15 min. The concentration range of the standard solution was between 1.32 
and 76.5 µg/ml. 
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2.9 Statistical data analysis 
 
Results are expressed as the means of at least three experiments ± SD. 
Statistical data analysis was performed using the t-test with P<0.05 as a 
minimal level as significance. 
 
3. Results 
 
3.1 Formulations 
 
The gels with fluconazole, flutamide and flufenamic-acid were transparent and 
semisolid, whereas the gels with flumethasone-pivalate and fludrocortisone-
acetate exhibited a significant turbidity. All formulations showed a “ringing” 
effect. 
 
3.2 Solubility 
 
The solubility of the selected drugs was analysed in phosphate-buffer (pH, 7.4), 
which is the most commonly acceptor fluid. In order to obtain sink conditions, 
the solubility in the acceptor medium was analysed and presented in Table 1. 
As a general rule, the concentration of the permeant should not be allowed to 
exceed 10% of saturation solubility [7].  
 
3.3 Rheological investigations 
 
Temperature can largely influence the viscoelastic properties of cubic phase 
systems [8]. In order to determine the temperature influence on the viscoelastic 
properties first changes in the ratio of viscous and elastic properties of the 
placebo gel were investigated with increasing temperature (Fig. 1). From the 
aspect of rheology, tan δ is defined as G’’/G’. As seen, the elastic modulus of 
the samples is dominating due to tan δ far below 1. Attention should be paid to 
the fact that tan δ is almost independent of the shearing frequency, which is 
completely different from results at the moderate and high temperatures. The 
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result demonstrates a dominant elastic behaviour exhibiting strong crystal like 
properties of the cubic gel at the investigated temperatures. This is confirmed 
by a recent publication on a similar gel [8]. Except at the temperature of 37°C 
the shape of the curves from 15°C to 32°C is very similar. One reason for the 
difference at 37°C might be the approximation to the melting point of the cubic 
gel.  
 
0,00
0,05
0,10
0,15
0,20
0,25
0,30
0,35
0,40
0,45
0,50
0,1 1 10 100
w [rad/s]
ta
n 
δ
15°C
25°C
28°C
32°C
37°C
 
Figure 1 tan δ (G’’/G’, the ratio of viscous and elastic components) as function of temperature 
and shear frequency for the cubic placebo-gel. Indicated values are means (± SD) of three 
experiments. 
 
Next step should be the rheological investigations of the drug containing gels in 
terms of G’ and G’’ at 25°, 28°, 32° and 37°C compared to the placebo gel. In 
Fig 2(A-F) the influence of the incorporated drugs on G’ and G’’ at different 
temperatures are presented. Although only 1 % (w/w) of model drugs were 
incorporated, significantly differences in the elastic modulus G’ and viscous 
modulus G’’ were observed compared to the placebo gel. The temperature 
exhibited an influence mainly on the elastic behaviour. One would expect a 
decrease of G’ as well as of G’’ with increasing temperature, however the 
placebo gel (Fig. 2F) showed an increasing G’ until 32°C and then a “one third” 
decrease of G’ at 37°C compared to G’ at 32°C.   
The pattern of the block-diagrams (Fig. 2A-F) shows no influence of fluconazole 
on the G’ values compared to the placebo gel. This indicates only a little 
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interaction between the incorporated drug and the microstructure of the gel. On 
the other hand fludrocortisone–acetate, flumethasone-pivalate, flutamide and 
flufenamic-acid caused increased G’ values at all tested temperatures 
compared to the placebo gel (Fig. 2F).  
The highest G’ values at 25°C were 5.9x105 Pa and 5.7x105 Pa at 10.2 Hz 
measured with flumethasone-pivalate and flufenamic-acid, respectively. This 
fact implies a significant interaction of the incorporated drug with the 
microstructure of the cubic gel system. However, with further increase of the 
temperature the G’ value of fludrocortisone-acetate, flumethasone-pivalate and 
flufenamic-acid decreased to a value in the range of G’ of the placebo gel. At 
skin temperature of about 32°C the gel with incorporated flutamide exhibited a 
different influence. In this case the G’ value of the flutamide gel showed the 
lowest G’ in comparison to the placebo gel. Moreover the elastic G’ and viscous 
G’’ value decreased further at 37°C and have about the same viscous and 
elastic properties. This behaviour might be due to the vicinity to the melting 
point of the gel-system. This is in agreement with literature data [8]. 
Regarding the viscous G’’ values an influence of the drugs could be observed 
too. The G’’ values of fluconazole-gels are in the same range as the G’’ values 
of the placebo gel, whereas the G’’ values of fludrocortisone-acetate-gels, 
flufenamic-acid-gels and fludrocortisone-acetate-gels were significantly lower. 
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Figure  2(A-F) Comparison of the elastic modulus G’ and viscous modulus G’’ of the drug 
containing cubic gel ( each 1% drug) to the placebo gel at 25°C, 28°C, 32°C and 37°C 
measured at 10,2 Hz. Fluconazole (A), fludrocortisone-acetate (B), flumethasone-pivalate (C), 
flutamide (D), flufenamic-acid (E), placebo gel (F). Indicated values are means (± SD) of three 
experiments. 
 
3.4 Skin diffusion 
The release data obtained in the present work are presented in Fig. 3. As 
shown in Fig. 3 the cumulative permeation rate of fludrocortisone-acetate, 
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flumethasone-pivalate and flutamide are nearly in the same range between 9 µg 
and 19 µg /cm2 after 48 h of diffusion and were not significantly different. 
Whereas the cumulative amount released of flufenamic-acid is about 21-fold 
higher after the same diffusion time. Interestingly the lag time was about 10 
hours in these four cases. For fluconazole the highest cumulative permeation 
rate was measured, which could be expected from the solubility data in the 
acceptor medium (Table 1). The amount was about 6-fold higher compared to 
the tested flufenamic-acid and about 125-fold higher compared to the other 
tested drugs.  
 
Table 1 Saturation solubility of fluconazole, fludrocortisone-acetate, 
flumethasone-pivalate, flutamide and flufenamic-acid in mg/ml 0.012 M 
phosphate buffer (pH, 7.4); n=3 
Drug              Solubility ± SD 
                            mg/ml   
  
Fluconazole  5,961 ±0,398 
Fludrocortisone-acetate  0,026 ±0,008 
Flumethasone-pivalate  0,053 ±0,001 
Flutamide   0,020 ±0,001 
Flufenamic-acid   1,536 ±0,026 
 
 
0
200
400
600
800
1000
1200
1400
1600
1800
0 10 20 30 40 50 60
time [h]
µg
/c
m
² p
er
m
ae
tio
n
 
Figure 3 Skin diffusion profiles of fluconazole, flufenamic-acid, fludrocortisone-acetate, 
flumethasone-pivalate and flutamide through porcine skin in µg/cm² over 48 h of diffusion. 
Fluconazole (♦), flufenamic-acid (●), fludrocortisone-acetate (▲), flumethasone-pivalate (■) and 
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flutamide (x). Indicated values are means (±SD) of three experiments. 
 
 
3.5 Chemical stability 
 
The chemical stability of fluconazole, fludrocortisone-acetate, flumethasone-
pivalate, flutamide and flufenamic-acid is presented in Fig. 4. As indicated there 
was no significant decrease of the drug amount in the presented gel during the 
whole observation period. Moreover on the HPLC-chromatograms no 
degradation products could be detected. Beside this, the visual observation of 
all formulations showed no signs of microbial contamination. 
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Figure 4   Drug amount of fluconazole (♦), flufenamic-acid (●), flutamide (x), flumethasone-
pivalate (■) and fludrocortisone-acetate (▲) in % (w/w) incorporated in the cubic-gel over an 
observation period of 10 weeks. Indicated values are means (±SD) of three experiments. 
 
4. Discussion 
 
A transparent “ringing gel” consisting of surfactants, paraffin oil and water has 
been used as vehicle in order to investigate in vitro skin permeation-studies, 
chemical stability and rheological behaviour of selected different fluorinated 
drugs fluconazole, fludrocortisone-acetate, flumethasone-pivalate, flutamide 
and flufenamic-acid.  
Incorporation of drug in cubic phase can cause phase transformation to lamellar 
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or reversed hexagonal phase depending on the polarity and concentration of 
the drug, which may affect the release profile [9]. Depending on the 
physicochemical properties of the drug , it may reside in the lipid bilayer or the 
aqueous channels of the gel and the location of the drug in the gel may 
influence its release [9].  
As already described in other reports gel microemulsions are good vehicles for 
fluconazole drug delivery [10]. These results could also be confirmed by our 
studies. Therefore for fluconazole an orally active antifungal agent which is 
used in the treatment of superficial and systemic candidiasis and in the 
treatment of cyrptococcal infections the presented cubic gel showed excellent 
vehicle properties. The released cumulative amount of fluconazole from the 
presented cubic gel was even higher compared to a similar gel microemulsion 
described in an other publication [10], where mice skin was used, which is 
known as much more permeable compared to porcine skin [11].  
Regarding the lipophilic non steroidal anti-inflammatory flufenamic-acid with 
potent anti-inflammatory and analgesic effects mediated by the inhibition of 
prostaglandin synthesis the presented cubic gel showed also excellent vehicle 
properties. For the corticosteroid fludrocortisone-acetate, which is commercially 
available in compressed tablets [4] the cumulative amount released was in the 
same range as the mostly dermal used flumethasone-pivalate. Fludrocortisone-
acetate is currently used for the treatment of several diseases from endocrine 
and non-endocrine origin [12]. For flumethasone-pivalate a difluorinated 
corticosteroid with anti-inflammatory and vasoconstrictive properties available in 
products like Locacorten®, Vioform® etc. the cubic gel might be a possibility for 
a new drug vehicle.  
Another agent with a hair growth potential is the nonsteroidal anti-androgen 
flutamide. This drug was introduced as a new potent compound for treatment or 
prostatic carcinoma. The systemic administration of flutamide causes several 
unwanted side effect, such as reducing libido and impairing spermatogenesis in 
men and feminizing male fetuses in pregnant women. Topical administration, 
therefore, is an important goal for such a drug, especially if indicated for skin 
disorders [13]. The release studies of flutamide from the cubic gel showed 
reasonable but lower skin permeation compared to a previous published report 
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[13] where phosphate buffer and ethyl alcohol were used as acceptor medium. 
This additive could be one of the reasons for the higher cumulative released 
amount of flutamide to our results. 
To explain a probable mechanism by which cubic gels, structurally closely 
related to microemulsions, enhance the release and percutaneoeus absorption 
of drugs efficiently, the histological and histochemical structure of the stratum 
corneum must be taken into consideration.  
A dermally applied microemulsion is expected to penetrate the stratum corneum 
and to exist intact in the whole horny layer, altering both the lipid and the polar 
pathways [10]. The lipophilic domain of the cubic gel can interact with the 
stratum corneum in many ways. The drug dissolved in the lipid domain of the 
microemulsion can directly partition into the lipids of the stratum corneum, or the 
lipid vesicles themselves can intercalate between the lipid chains of the stratum 
corneum, thereby destabilizing its bilayer structure. These interactions will lead 
to increased permeability of the lipid pathway to the drugs. 
On the other hand, the hydrophilic domain of the cubic gel can hydrate the 
stratum corneum to a greater extent, and plays an important role in the 
percutaneous uptake of drugs. When the aqueous fluid of the cubic gel enters 
the polar pathway, it will increase the interlamellar volume of the stratum 
corneum lipid bilayers, resulting in the disruption of its interfacial structure. 
Since some lipid chains are covalently attached to corneocytes, hydration of 
these proteins will also lead to the disorder of lipid bilayers. Similarly, swelling of 
the intercellular proteins may also disturb the lipid bilayers; a lipophilic penetrant 
can then permeate more easily through the lipid pathway of the stratum 
corneum. 
In fact, not such mechanism could be considered in explaining the superiority of 
the microemulsion or cubic gel over the other vehicles, but the combined effect 
of both the lipophilic and hydrophilic domains was responsible for its enhancing 
activity [10]. 
But not only the excellent vehicle properties of the cubic gel might be an 
advantage, but also the high chemical stability of the incorporated drugs could 
be an important factor for using the cubic gel as drug delivery system. As 
mentioned in earlier reports the chemical stability of various drugs incorporated 
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in this new gel formulation was very high [14]. This could also be confirmed by 
our studies. High chemical stability of the model drugs could be obtained over 
the whole observation period. However, the here investigated drugs showed 
also good chemical stability properties in other matrices like tablets, solutions 
and powders [4, 10, 15]. 
As mentioned above as well the chemical structure of the incorporated drugs as 
the temperature has an important effect on rheological behaviour of the 
microstructure of the cubic gel. At moderate temperature, the rheological 
properties and inner structure of cubic liquid crystal change hugely. 
Furthermore, the influence of the incorporated drugs on the viscoelastic 
properties was dependent on their chemical structure and can probably be 
related to the micro-structure of the cubic gel. This effect might be confirmed 
also by the low aqueous solubility of the model drugs. As mentioned above the 
cubic gel with the incorporated flumethasone-pivalate and fludrocortisone-
acetate exhibited a significant turbidity. This could be an indication that drug 
particles may be suspended in the aqueous component of the gel, which might 
influence the elastic behaviour of the gel system. This fact could be a reason for 
the high elastic G´ of those two incorporated drugs. Therefore additional 
biophysical experiments like micro-DSC and NMR-self-diffusion experiments 
are in progress to specify more the changes in liquid crystalline microstructure 
and molecular movement. 
 
 
 
 
 
 
 
 
 
 
 
 
Publications 45
 
5. References 
 
1. H. Chen, X. Chang, D. Du, J. Li, H. Xu,  X. Yang, Microemulsion-based 
hydrogel formulation of ibuprofen for topical delivery, Int. J. Pharm. 315 
(2006) 52-58. 
2. H. Kählig, C.Valenta, U. Dampfhart, B. G. Auner, Rheology and NMR 
self-diffusion experiments as well as skin permeation of diclofenac-
sodium and cyproterone acetate of new gel preparations, J. Pharm. Sci. 
94 (2005) 288-296. 
3. Wang, Y.P., Shuming; Shi, Yanping, Determination of fluconazole 
injection and its related substance by HPLC, Zhongguo Yiyuan Yaoxue 
Zazhi, (2003) 23(5) 268-270. 
4. S. Cisternino, J. Schlatter, J.L. Saulnier, Stability of Fludrocortisone 
acetate solutions prepared from tablets and powder, Eur. J. Pharm. 
Biopharm. 55 (2003) 209-213. 
5. L. Gagliardi, D. De Orsi, M. R. Del Giudice, F. Gatta, R. Porra, P. 
Chimenti, D. Tonelli, Development of a tandem thin-layer 
chromatography -high- performance liquid chromatography method for 
the identification and determination of corticosteroids in cosmetic 
products, Analytica Chimica Acta, 457 (2002) 187-198. 
6. J. Leibinger, M. Kapas, New and validated high-performance liquid 
chromatographic method for determination of hydroxyflutamide in human 
plasma, J. Pharm. Biom. Anal. 14 (1996) 1377-1381. 
7. K.R. Brain, K.A.W., A.C. Watkinson, Investigation of skin permeation in 
vitro, in: M.S. Roberts, K.A. Walters, Dermal Absorption and Toxicity 
Assessment. Marcel Dekker, New York, 1998, pp.161-187. 
8. H. Wang, G. Zhang, Z. Du, Q. Li, W. Wang, D. Liu, X. Zhang, Effect of 
Publications 46
 
temperature on dynamic rheological behaviour of discontinuous cubic 
liquid crystal, J. Colloid Interface Sci. 300 (2006) 348-353. 
9. J. Shah, Y.Sadhale, D. Chilukuri, Cubic Phase gels as drug delivery 
systems, Adv. Drug Del. Rev. 47 (2001) 229-250. 
10. H.M.El Laithy, K.M.F.El-Shaboury, The development of cutina lipogels 
and gel microemulsions for topical administration of fluconazole, AAPS 
Pharm. Sci. Tech. 3 (2002) 1-9. 
11. R.C. Wester, H.I. Maibach, In vivo animal models for percutaneous 
absorption, in: R.L. Bronaugh, H.I. Maibach (Eds.), Percutaneous 
Absorption, Marcel Dekker, New York, 1985, pp. 251-266. 
12. S. Gibaud, N. Al Awwadi, C. Ducki, A. Astier, Poly (ε-caprolactone) and 
Eudragit® microparticles containing fludrocortisone-acetate, Int. J. 
Pharm. 269 (2004) 491-508. 
13. A. Sintov, S. Sserfimovich, A. Gilhar, New topical antiandrogenic 
formulations can stimulate hair growth in human bald scalp grafted onto 
nice, Int. J. Pharm. 194 (1999) 125-134. 
14. C. Valenta, B. Auner, I. Loibl, Skin permeation and stability studies of 5-
aminolevulinic acid in a new gel and patch preparation, J. Contr. Rel. 107 
(2005) 495-501. 
15. Miranda A, I. Carabella, M. Millan, Stability study of flutamide in solid 
state and in aqueous solution, Drug Dev. Ind. Pharm. 28 (2002) 413-22. 
 
 
 
 
 
 
Publications 47
 
4.2 Skin compatible lecithin drug delivery systems for fluconazole: effect    
of phosphatidylethanolamine and oleic acid on skin permeation 
Sonja Hoeller, Victoria Klang, Claudia Valenta¹ 
J. Pharm. Pharmacol. (2008) 60: 587-591 
 
Department of Pharmaceutical Technology and Biopharmaceutics 
Faculty of Life Sciences 
Althanstrasse 14 
1090 Vienna 
AUSTRIA 
 
¹Corresponding Author: Claudia Valenta 
Department of Pharmaceutical Technology and Biopharmaceutics 
Faculty of Life Sciences  
Althanstrasse 14 
1090 Vienna 
AUSTRIA 
 
E-mail: claudia.valenta@univie.ac.at 
Tel: +43 1 4277 55 410 
Fax: +43 1 4277 9554 
 
 
 
 
 
 
Publications 48
 
Abstract 
The purpose of the present study was to evaluate skin compatible drug delivery 
systems for fluconazole. Pseudo-ternary phase diagrams were constructed 
composed of different soybean lecithins/oil/isopropanol and water. The role of 
the various lecithin compositions is expressed in different resulting isotropic 
areas. Based on these phase diagrams two systems were chosen as drug 
delivery vehicle for fluconazole. On one hand the influence of 
phosphatidylethanolamine and on the other hand the influence of the oil 
component was investigated on the skin permeation of fluconazole. The more 
phosphatidylethanolamine the higher was the fluconazole skin permeation 
independent of the hydrophilicity of the system. The influence of oleic acid and 
isopropylmyristate as an oil component resulted in a preference of penetration 
enhancing effect of the oleic acid containing microemulsion.  
 
 
Keywords: Microemulsions; Fluconazole; Soybean-lecithin; Skin permeation; 
Phosphatidylethanolamine 
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1. Introduction 
Microemulsions are clear isotropic, thermodynamically stable liquids with 
ultralow interfacial tension, large interfacial area and the capacity to solubilize 
both aqueous and oil-soluble compounds (Paul et al., 2001). The different 
resulting structures that were formed by mixing various ratios of surfactants 
have been studied and systematized in detail during the last years (Aboofazeli 
and Lawrence, 1993; 1994; 1995; Wang et al., 2006). These self-assembled 
structures are tuneable by changing the ratio and the concentrations of the 
ingredients. 
In order to affect the flux during the skin several permeation enhancers were 
used as ingredients in such formulations. Oleic acid and several other fatty 
acids are able to interrupt the lipid barrier in the stratum corneum by forming 
separate domains, which interfere with the continuity of the multilamellar 
stratum corneum and may induce highly permeable pathways (Peltola et al., 
2003; Hadgraft, 2001; Ongpipattanakul et al., 1991). Also isopropylmyristate 
another non toxic ingredient is well known as permeation enhancer in 
transdermal formulations, although the mechanism of its action is poorly 
understood (Goldberg-Cettina et al., 1995).  
The aim was to construct pseudo-ternary phase diagrams consisting of 
lecithin/isopropanol/oil and water in order to see how different commercially 
available soybean lecithins influences the formation of microemulsions and 
transport of the entrapped lipophilic drug through skin. Also the influence of 
oleic acid or isopropylmyristate as an oil component was compared.  
2. Material and methods 
2.1. Materials 
Fluconazole (CAS: 86386-73-4) was purchased from Kemprotec (UK). 
Soybean-lecithins with different concentrations of phosphatidylcholine (PC), 
lysophosphatidylcholine (LC) and phosphatidylethanolamine (PE), namely 
Lipoid S45 (CAS: 745303-1), Lipoid S75 (CAS: 776099-1) and Lipoid S100 
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(CAS: 790535-5) were kindly donated by Lipoid GmbH (Ludwigshafen, Ge). 
Isopropanol was supplied by Merck (Hohenbrunn, Ge). Isopropylmyristate (IPM) 
was purchased from Sigma-Aldrich (St.Louis, USA) and Oleic acid (OA, EG.Nr: 
204-007-1) was supplied from Herba Chemosan (Vienna, Au). 
2.2 Construction of pseudo-ternary phase diagrams 
In order to construct pseudo-ternary phase diagrams appropriate amounts of 
three different lecithins (S100, S75 and S45), OA and isopropanol were weight 
out to vials and stirred at room temperature until a clear solution was obtained. 
Distilled water was added drop-by-drop and stirred to attain equilibrium. After 
being equilibrated, the mixture was assessed visually and under cross 
polarizers for the absence of a liquid crystalline (LC) phase in order to 
determine the boundaries of microemulsions identified by isotropic phases and 
birefringent liquid crystalline domains.  
2.3 Microscopic characterisation of microemulsions 
Polarizing light microscopy studies were carried out at room temperature using 
an Optiphot- microscope (Nikon GmbH, Ge) in order to get more information on 
the microscopic structure of the systems.    
2.4 Formulations 
The formulations were prepared as already described and the compositions are 
presented in Table 1. System I consisted of 25% oil, 25% surfactant, 25% co-
surfactant and 25% water. System II consisted of 40% oil, 25% surfactant, 25% 
co-surfactant and 10% water. Both systems were prepared also with OA and 
IPM.  
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Table 1 Composition of the microemulsions in %, (w/w)    
Formulation Code IPM OA S100 S75 S45 ISO Water Flu 
System I         
I-1 25 -- 25 -- -- 25 25 1 
I-2 25 -- -- 25 -- 25 25 1 
I-3 25 -- -- -- 25 25 25 1 
I-4 -- 25 25 -- -- 25 25 1 
I-5 -- 25 -- 25 -- 25 25 1 
I-6 -- 25 -- -- 25 25 25 1 
System II         
II-1 40 -- 25 -- -- 25 10 1 
II-2 40 -- -- 25 -- 25 10 1 
II-3 40 -- -- -- 25 25 10 1 
II-4 -- 40 25 -- -- 25 10 1 
II-5 -- 40 -- 25 -- 25 10 1 
II-6 -- 40 -- -- 25 25 10 1 
Abbreviations: IPM: isopropylmyristate; OA: oleic acid; S100: Lipoid S100 (consisting of 98.40 
%PC, 0.3% LC and < 0.1% PE); S75: Lipoid S75 (consisting of 69.90% PC, 2.20% LC and 
8.40% of PE); S45: Lipoid S45 (consisting of 54.90 PC, 1.0% LC and 16.90 % PE); ISO: 
isopropanol; Flu: fluconazole 
2.5 In vitro skin permeation study 
 Porcine abdominal skin was shaved and then prepared with a dermatome (GB 
228R, Aesculap) set at 1.0 mm. The permeation of fluconazole was investigated 
as described in a prior study (Hoeller and Valenta, 2007).  
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2.6 HPLC analysis 
For the quantification of fluconazole by HPLC (Perkin Elmer, US) an already 
experienced procedure was used (Hoeller and Valenta, 2007). Calibrations 
curves were calculated on the basis of peak area measurements of using 
standard solutions. They were generated with a correlation coefficient of 
0.9993. The concentration range of the standard solution for fluconazole was 
between 13.66 and 109.3 µg/ml. 
2.7 Statistical data analysis 
Results are expressed as the means of at least three experiments ± SD. 
Statistical data analysis for Figure 3A-B were performed using the Kruskal-
Wallis test (p<0.05). 
3. Results 
3.1 Microscopic characterisation of microemulsions  
The microscopic pictures are presented in Figure 1A-F. Microemulsions were 
identified obviously on their clear isotropic texture, which appears under 
polarized light as black planes (Fig. 1A). Such phases are usually produced at 
very high surfactant concentrations and low water content. As the surfactant 
concentration was further diluted with water fluent drop aggregates existed, 
designated as Fig. 1B. Typical ‘mosaic’ textures (Fig. 1C) appeared mostly at a 
very low surfactant concentration of about 10-20 %. At a higher surfactant 
concentration of about 25-30 % various liquid crystalline structures were 
obtained (Fig. 1D-F). Such structures showed birefringence under polarized 
light and appeared mostly at a mixing ratio with low oil content (10-20 %).  At a 
surfactant/co-surfactant concentration of about 30% typically lamellar liquid 
crystalline structures were obtained, while at higher surfactant concentrations 
hexagonal phases were produced.  
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A)     B)               C) 
       
D)            E)       F) 
Figure 1(A-F) Micrographs of the phase textures obtained by the construction of the pseudo-
ternary phase diagrams (Surfactant/co-surfactant/oil/water). A) isotropic texture: 50/40/10, B) 
fluent drop aggregates: 10/10/80, C) mosaic texture: 20/30/50, D-F) liquid crystalline textures: 
30/10/60; 30/10/60; 30/10/60 
3.2 Pseudo-ternary phase diagrams 
The overlaid pseudo ternary phase-diagrams are presented in Figure 2. The 
largest isotropic area was obtained by Lipoid S75, which contains 69.90% of 
phosphatidylcholine, followed by the narrowed area induced by Lipoid S100 
with the highest content of phosphatidylcholine. A Comparison of the isotropic 
area from S45 (lowest amount of PC) with S75 and S100 showed an extension 
in the water and oil region. The possible percent compositions for isotropic 
regions are from about 45 to 85 % of surfactant/co-surfactant and from about 5 
to 55 % of oil and from about 5 to 30 % of water.  
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Figure 2 Overlaid pseudo-ternary phase diagrams of the oil-surfactant/co-surfactant-water 
systems using three different lipid compositions produced at room temperature (the marked 
area represents the microemulsion region); Pale grey: Lipoid S75; black: Lipoid S100; white: 
Lipoid S45 
Point I: System I consisting of 25 % oil, 25 % lipid, 25 % isopropanol and 25 % water. 
Point II: System II consisting of 40 % oil, 25 % lipid, 25 % isopropanol and 10 % water.  
3.3 In vitro skin permeation study  
The results are presented in Figure 3A-B and the cumulative amount of the 
permeation of fluconazole is included in Table 2. 
System I: The microemulsion with OA showed higher cumulative amount of 
fluconazole after 48 h of diffusion through skin than those of IPM (Fig. 3A). The 
rank order of cumulative amount permeated in case of OA is: I-6 > I-5 > I-4. The 
highest permeation could be obtained from I-6. This is the formulation with the 
lowest content of PC (S45), but a high content of PE (19.90 %). On second 
position is the lecithin (S75) with still 8.4 % PE. The formulation with the highest 
amount of PC, but almost no PE showed lower skin permeation (S100). 
Regarding the formulation with IPM the highest permeability was obtained from 
I-2. For I-1 and I-3 about the same amount of fluconazole was released. A 
comparison of the permeation of I-1, I-2 and I-3 with I-6 with OA indicated a 
significant higher cumulative amount of fluconazole of the latter (Kruskal-Wallis-
Test p <0.05).  
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System II: In System II a preference of higher cumulative amount of fluconazole 
through skin can be seen of OA containing preparation (Figure 3B). Comparing 
II-3 containing IPM with II-6 containing OA indicated a significant higher 
cumulative amount permeated of fluconazole from II-6 (Kruskal-Wallis test p 
<0.05). The rank order of the results regarding the lecithin compositions are in 
case with OA: II-6 > II-5 > II-4 and in case with IPM: II-2 > II-3 > II-1. Again 
microemulsion II-6 containing the highest amount of PE exhibited the highest 
cumulative amount of fluconazole through skin in contrast to II-4 and II-5. All 
cumulative amounts permeated of fluconazole after 48 h of diffusion are 
presented in Table 2.  
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Figure 3 A-B Fluconazole diffusion through excised porcine skin after 48h of diffusion times 
from microemulsion systems II and I. A) Microemulsion system I; B) Microemulsions system II; 
n=3 
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Table 2 Comparison of the cumulative drug amount (µg/cm²) of fluconazole 
permeated after 48 h of diffusion time through porcine skin, n=3 
System I 
      Cumulated drug amount  
                   (µg/cm²) System II
  Cumulated drug amount 
               (µg/cm² ) 
I-1 988,99 ±197,44 II-1 1106,81  ±114,90 
I-2 1119,97 ±114,90 II-2 1160,76  ±93,89 
I-3 981,66 ±68,51 II-3 1147,01  ±124,56 
I-4 1411,97 ±55,34 II-4 1258,80  ±133,87 
I-5 1517,24 ±71,35 II-5 1372,57  ±54,48 
I-6 1596,65 ±102,89 II-6 1622,84  ±31,32 
 
4. Discussion 
Lecithin has been shown to enhance skin penetration by interfering with skin 
lipids and therefore induce a change of the skin lipid fluidity (Paolino et al., 
2002). It was the question whether the composition of different lecithins has an 
impact on building the isotropic phase as well as on skin permeation. The 
results of the phase diagrams show different sizes of isotropic area. Lipoid S75 
achieved the biggest area. The component lysophosphatidylcholine and 
phosphatidylethanolamine may be responsible for this. Lipoid S45 contains also 
these ingredients and they may influence the effective critical packing 
parameter in a different manner as described also in previous studies 
(Aboofazeli and Lawrence, 1994). Recently in one study the effect of PC and 
PE was investigated with respect to the transepidermal water loss (TEWL). In 
one publication PC and PE in a concentration of 10mg/cm² significantly reduced 
the TEWL and PE was approximately twofold more effective than PC (Raney 
and Hope, 2006). The data are consistent with formation of extensive 
hydrophobic interactions between the skin and the outwardly facing acyl chains 
of the inverted hexagonal phase adapted by PE. In our case the amount of 
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applied PE was about 25 mg/cm² calculated from the applied formulation of   
0.6 g containing 25 % Lipoid S45 and containing about 17 % PC. The here 
applied doses would be sufficient to induce such hydrophobic interactions 
between skin and phosphatidylethanolamine. This could be one possible reason 
for the increase of fluconazole permeation. 
OA versus IPM were checked for their percutaneous enhancing effect. The 
highest permeation of fluconazole was achieved with OA as oil component. This 
observation seems compatible with the main mechanism suggested for the 
action of OA as permeation enhancer, by increasing stratum corneum 
permeability. Therefore a facilitated membrane diffusion could be achieved 
(Touitou et al., 2002; Moser et al., 2001). It has been shown that OA is more 
effective to highly hydrophilic compounds, which supports the use in 
combination with the hydrophilic fluconazole. In our case this hypothesis was 
confirmed because in the more hydrophilic microemulsion I the penetration 
enhancer effect of OA was more pronounced than in the more lipophilic 
microemulsion II.  
 
5. Conclusion  
It is possible to create skin compatible lecithin microemulsions having high 
fluconazole diffusion through porcine skin, whereas the 
phosphatidylethanolamine content seems to play a major role in increasing the 
skin permeability.  
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Abstract 
 
Charged drug delivery systems are interesting candidates for the delivery of 
drugs through skin. In the present study, it was possible to create negatively 
and positively charged oil/water nanoemulsions by using sucrose laureate and 
polysorbate 80 as non-ionic surfactants. The positively charged nanoemulsions 
were generated by adding cationic phytosphingosine (PS). The relationship 
between the physicochemical properties of the nanoemulsions was shown by 
particle size and zeta potential measurements. These properties were 
dependent on the type of non-ionic surfactant and the concentration of PS. 
Furthermore the cationic PS had a positive impact on the skin permeation rates 
(flux) of the incorporated model drugs fludrocortisone acetate and flumethasone 
pivalate. An enhancement factor between 1.1 and 1.5 was obtained in relation 
to the control. The interaction of pre-impregnated porcine skin with positively 
and negatively charged nanoemulsions was confirmed by DSC analysis. The 
generated DSC-curves showed a slight difference in the phase transition 
temperature assigned to the characteristic lipid transition. However, it was not 
possible to assign the effect to one of the ingredients in the multicomponent 
system.  
 
 
Keywords: nanoemulsions, sucrose ester, polysorbate 80, particle size, zeta 
potential, skin permeation, DSC 
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1. Introduction 
 
Nanoemulsions possess numerous advantages including the possibilities of 
controlled drug release and drug targeting, and the incorporation of a great 
variety of therapeutic actives (Calderilla-Fajardo et al., 2006). Usually the 
droplets achieve a size range between 50-200 nm. Unlike microemulsions they 
are stabilized by non-ionic surfactants and/or polymers exhibiting a steric 
stabilisation effect. Due to their small particle sizes, nanoemulsions are able to 
penetrate easily through the skin layers and enhance skin penetration of 
incorporated drugs (Tadros et al., 2004). Another important advantage is the low 
surfactant concentration compared to microemulsions (Tadros et al., 2004). 
Several preparation techniques such as spontaneous emulsification, phase 
inversion temperature (PIT) emulsification, phase inversion composition and 
high pressure homogenisation are known. The colloid-chemical structure 
depends thereby on these processes (Sonneville-Aubrun et al., 2004).  
Due to their effectiveness for drug solubilization nanoemulsions offer an 
alternative for the administration of poorly water soluble drugs. This leads to 
improved efficacy and compliance because of reduced side effects (Kelmann et 
al., 2007). Nevertheless the use of safe and skin friendly ingredients is desirable 
for such colloidal formulations. As already reported, Lecithin, a natural mixture 
can fulfil these requirements, generally it is non-irritating and non-sensitizing for 
animal and human skin (Fiume, 2001; Paolino et al., 2002). Moreover lecithin 
compounds present an affinity to cellular membranes thus leading to an 
increased absorption of several drugs (Paolino et al., 2002). Sucrose esters are 
also non-irritant and biodegradable surfactants and therefore suitable for 
pharmaceutics and cosmetics. As previously published sucrose esters are 
promising candidates for enhanced drug permeability through skin showing lipid 
extraction and fluidization of the stratum corneum. Among the group of sucrose 
esters sucrose laureate has already been used to enhance skin permeability 
(Cazares-Delgadillo et al., 2005; Calderilla-Fajardo et al., 2006). 
Cationic compounds can also have a positive effect on skin permeation, since 
the skin carries a negative surface charge due to the negatively charged 
residues of proteins (Yilmaz and Borchert, 2005). One candidate for this 
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purpose could be the physiological phytosphingosine (PS), a natural compound 
in the human body as well as in the stratum corneum. PS exhibited anti-
inflammatory and antimicrobial effects both being interesting for topical use 
(Yilmaz and Borchert, 2005; M.Farwick et al., 2007). 
The aim of the present study was to design physically stable nanoemulsions 
consisting of lecithin, vitamin E, PS, sucrose laureate and polysorbate 80, 
respectively. After the physicochemical characterisation by particle size and zeta 
potential measurements the influence of surfactant type and PS on skin 
permeation rates of the model drug fludrocortisone acetate was investigated. In 
order to confirm the influence of the cationic PS on skin diffusion additional 
permeation studies were performed using flumethasone pivalate in the 
polysorbate 80 nanoemulsion. Furthermore information about the possible 
interactions with skin lipids should be provided by DSC measurements of 
porcine skin samples after exposure to the various nanoemulsion formulations.  
 
2. Materials and Methods 
2.1 Materials 
Fludrocortisone acetate (CAS: 514-36-3) was purchased from Sigma-Aldrich 
(St.Louis, USA). Flumethasone pivalate (CAS: 2002-29-1) was supplied from 
Kemprotec (Middlesbrough, U.K.). Phytosphingosine (PS) was kindly provided 
by Degussa (Cosmoferm BV, NL). Lipoid S-75 was obtained from Lipoid GmbH 
(Ludwigshafen, Ge), containing 69.9% phosphatidylcholine, 8.4% 
phosphatidylethanolamine, 2.2% lysophosphatidylcholine according to 
manufacturer’s specifications. Sucrose laureate (SL, Ryoto Sugar Ester® L-
1695) was gently donated by Mitsubishi-Kasei Food Corporation (Tokio, J). 
Polysorbate 80 and the antioxidant α-tocopherol were supplied by Pauli GmbH 
& Co.KG (Vienna, A). PCL-liquid (Etylhexanoate) was purchased from Symrise 
GmbH & Co.KG (Holzminden, Ge). All other chemicals used were of analytical 
reagent grade and used as received without any further purification.  
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2.2 Formulations 
 
The nanoemulsions were prepared by mixing the separately prepared aqueous 
and oily phases. The aqueous phase containing sucrose laureate or 
polysorbate 80 and distilled water was heated up to 50 °C under slight mixing. 
When PS was incorporated it was dissolved in the oil phase, containing PCL-
Liquid, Lipoid S75, α-tocopherol and model drug (1%). The two phases were 
merged and pre-homogenised for 3 min with an ultra-Turrax (Omni 500) at 2500 
rpm and continuously stirred for 24 h at room temperature. Afterwards the raw 
formulation was pre-homogenised once more for 3 min at 50°C and further 
homogenised with a high-pressure homogeniser (EmulsiFlex-C3, Avestin) for 
12 homogenisation cycles at 600 bars. In Table 1 all formulations performed 
with code names and their percentage compositions are presented.  The 
meaning of the code names is detailed below Table 1.  
 
Table 1 Composition of the nanoemulsion formulations and abbreviations 
Excipients Nanoemulsion composition (%w/w)       
  NL NL-0.4PS NL-0.6PS NT NT-0.4PS NT-0.6PS 
Lipid Phase       
PCl-Liquid 20 20 20 20 20 20 
Lipoid S75 4 4 4 4 4 4 
alpha-Tocopherol  1 1 1 1 1 1 
Phytosphingosine (PS)  -- 0.4 0.6  -- 0.4 0.6 
Fludrocortisone acetate 1 1 1 1 1 1 
Aqueos phase       
Sucrose laureate L-1695 1 1 1  --  --  -- 
Polysorbate 80  --  --  -- 1 1 1 
Distilled water to 100 100 100 100 100 100 
Abbreviations:       
NL,            sucrose laureate  nanoemulsion without PS   
NL-0.4PS, sucrose laureate nanoemulsion with 0.4% PS  
NL-0.6PS, sucrose laureate nanoemulsion with 0.6% PS  
NT,            polysorbate 80 nanoemulsion without  PS    
NT-0.4PS, polysorbate 80 nanoemulsion with 0.4% PS    
NT-0.6PS, polysorbate 80 nanoemulsion with 0.6% PS   
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2.3. Nanoemulsion characterisation 
 
2.3.1. Particle size 
 
The mean particle size and size distribution were determined by photon 
correlation spectroscopy with a Zetasizer Nano ZS (Malvern, UK) at 25°C. Each 
nanoemulsion was diluted to the appropriate concentration with distilled water to 
weak opalescence. The size distribution was represented by the polydispersity 
index (PDI) values. Thereby PDI values lower than 0.25 indicate a close size 
distribution providing good stability of nanoemulsions due to the reduced 
Ostwald ripening (Yilmaz and Borchert, 2005). The measurements were 
performed using a He-Ne laser at 633 nm. The diameters were determined 
immediately after nanoemulsion preparation and checked over 10 weeks during 
storage at room temperature. 
 
2.3.2. Zeta Potential 
The surface charge was analysed using a Zetasizer Nano ZS (Malvern, UK) at 
25°C by measuring the zeta potential (ZP) of the preparations. For this purpose 
the samples were diluted with distilled water. The ZP characterises the surface 
charge of particles and thus gives information about repulsive forces between 
particles and droplets. Absolute higher values than 30 mV usually indicate good 
stability of the system (Müller, 1996). Also ZP values were measured after 
nanoemulsion preparation and checked over 10 weeks during storage at room 
temperature.  
2.3.3. Skin permeation experiments  
In vitro permeation studies with porcine abdominal skin were performed using 
Franz-type diffusion cells. Porcine abdominal skin was chosen as a model 
based on the similarity in permeability and morphology to human skin (Cazares-
Delgadillo et al., 2005). Abdominal porcine skin was shaved and then prepared 
with a dermatome (GB 228R, Aesculap) set at 1 mm and afterwards stored in a 
freezer at -20°C until use. Two hours prior to the experiment the samples were 
thawed. 
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The skin was clamped between the donor and the receptor chamber of Franz-
type diffusion cells having a permeation area of 1.13 cm². The receptor 
compartment was filled with 2 ml of 0.012 M phosphate buffer (pH, 7.4). The 
recently investigated solubility of the model drugs in 0.012 phosphate buffer 
(Hoeller and Valenta, 2007) guaranteed sink conditions. The diffusion cells were 
thermostated at skin surface temperature of 32°C and stirred by magnetic bars. 
The formulation (0.6 g) was gently placed in the donor chamber. Samples of 
200 µl were removed at defined time intervals for analysis and replaced 
immediately by an equal volume of fresh buffer. At least three parallel 
experiments were performed for each formulation. Each 20 µl of the samples 
were analysed for their drug content by HPLC (Perkin Elmer, US) consisting of 
an automatic auto sampler ISS-200, a pump and an UV-diode array detector. A 
previously reported method was used (Cisternino et al., 2003). Briefly, the used 
column was a Nucelosil 100 – 5 C18 column (240 mm x 4 mm; ARC-
Seibersdorf Austria) and the mobile phase consisted of acetonitrile and water 
(40:60 v/v), respectively. The detection wavelength was set at 240 nm and the 
flow rate was 0.8 ml/min for fludrocortisone acetate and 1.0 ml/min for 
flumethasone pivalate. Calibration curves were calculated on the basis of peak 
area measurements of the used standard solutions. The calibration curves had 
a correlation coefficient of 0.9998 and 0.9991, respectively. The concentration 
range of the standard solutions was between 3.87 - 124 µg/ml for 
fludrocortisone-acetate and between 3.48 -110.9 µg/ml for flumethasone 
pivalate.  
Additionally, the steady state flux J [μcm-2h-1] across the skin was calculated 
from the slope of linear portion of the cumulative amount permeated through the 
porcine skin per unit area versus time plot.  
 
2.3.4. Differential scanning calorimetry (DSC) 
 
DSC (Perkin Elmer DSC-7) was used to characterise the thermal transition of 
porcine skin samples of one individual that were either pre-impregnated with 
water or positively and negatively charged nanoemulsion formulations. The 
method used is already described (Valenta et. al., 2001). Briefly, prior to DSC 
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measurements about 25 mg of porcine skin were impregnated with 2 ml of 
water or differently charged nanoemulsions in a petri dish for 12 h. Porcine skin 
impregnated with water served as control. Afterwards the skin samples were 
blotted dry and then hermetically sealed within an aluminium holder and heated 
from 30 to 120°C at a heating rate of 5°C/min. The generated DSC-curves were 
compared to the control in terms of transition temperature and linear onset.  
Gravimetric analysis of all samples prior to DSC experiments showed average 
water content of about 72.91 % (w/w) ± 5.83.  
 
2.3.5. Statistical data analysis 
 
Results are expressed as the means of minimum three experiments ± S.D. 
Statistical data analysis was performed using the t-test with P<0.05 as a 
minimal level as significance. 
 
3. Results 
 
3.1. Formulations 
 
A visual inspection of the different formulations immediately after production 
showed liquid, whitish and well distributed nanoemulsions in all cases. 
 
3.2. Nanoemulsion characterisation 
The physicochemical properties of the formulations after 12 homogenisation 
cycles are shown in Table 2. As seen, the mean particle size depended on the 
type of surfactant and was strongly influenced by the presence of PS. In the 
sucrose laureate nanoemulsion the addition of PS increased the particle sizes 
in following manner: the higher the PS content, the higher the particle sizes of 
the nanoemulsions. In contrast to this in the polysorbate 80 nanoemulsion an 
increase from 0.4 % to 0.6 % PS decreased the particle size from 216 to 176 
nm, which is nearly the size of the PS free polysorbate 80 nanoemulsion. As 
expected the surface charge of the nanoemulsions shifted from negative to 
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positive by adding PS. The absolute values being above 45 mV indicate a good 
electrochemical stability. The PDI values lower than 0.25 pointed to close size 
distributions.  
Table 2     
Physicochemical properties of the nanoemulsions after 12 homogenisation 
cycles with a high pressure homogeniser. PDI, polydispersity index; PS, 
phytosphingosine. Indicated values are the average (±S.D.) of three experiments.
                          sucrose laureate nanoemulsion    polysorbate 80 nanoemulsion 
Property NL NL-0.4PS NL-0.6PS NT NT-0.4PS NT-0.6PS 
        
Particle size (nm) 161±0.7 215±2.8 254±2.2 170±3.8 216±26.6 176±2.1 
Zeta potential (mV) -62±0.4 +46±0.4 +48±0.7 -55 ±0.7 +45±0.7 +48±1.1 
PDI 0.12-0.22 0.22-0.25 0.06-0.10 0.15-0.18 0.13-0.18 0.10-0.14 
pH 7.21±0.05 8.96±0.19 6.69±0.12 5.3±0.08 6.7±0.06 7.1±0.12 
 
A set of experiments was performed over a pH-range from 5 to 8. Whereas the 
PS free nanoemulsions with sucrose laureate and polysorbate 80 showed a 
constant high ZP and a uniform particle size over the whole pH-range, the PS 
containing nanoemulsions exhibited a completely different behaviour (Fig 1 a, 
b). When 0.6 % PS was incorporated in sucrose laureate nanoemulsion (Fig. 
1a, black bars) the particle size increased dramatically up to pH 6.5. The 
biggest particle sizes of about 1200 nm were seen at pH 8.0. When the pH 
value was decreased from 8 to 5, the ZP values increased from about –10 mV 
to above +40mV in the nanoemulsions with PS. In case of the polysorbate 80 
nanoemulsion (Fig. 1b, black bars) the particle size was slightly increased but 
uniformly also by addition of 0.6% PS over the whole observed pH-range, which 
is an indication for a higher stability. The ZP changes followed the same pattern 
as in the sucrose laureate nanoemulsion at higher pH to negative.  
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a)       b)  
Figure 1 a, b Effect of pH on the mean particle size and zeta potential (ZP) from sucrose 
laureate and polysorbate 80 nanoemulsions. Indicated values are means (± S.D.) of three 
experiments. a) sucrose laureate nanoemulsions: white bars: mean particle size of NL; black 
bars: mean particle size of NL-0.6PS; -▲- zeta potential of NL; -●-   zeta potential of NL-0.6PS 
b) polysorbate 80 nanoemulsions: white bars: mean particle size of NT; black    bars: mean 
particle size of NT-0.6PS; -▲- zeta potential of NT; -●- zeta potential of NT-0.6PS  
 
The stability assessments of the tested nanoemulsions are shown in Fig. 2 a, b. 
As seen, a constant ZP and uniform particle size over an observation period of 
10 weeks are indicated in the PS free nanoemulsions (Fig. 2 a, b, white bars) as 
well as in the PS containing nanoemulsion with polysorbate 80 (Fig. 2a, grey 
and black bars). Although, the particle size is slightly increased in the PS 
containing preparation the nanoemulsion can be quoted as physically stable. In 
general, the polysorbate 80 nanoemulsion show particle sizes in the range from 
165-250 nm independent of the surface charge. 
 
Publications 70
 
0
100
200
300
400
500
600
700
0 10 15 22 29 35 49 63 70
time (days)
M
ea
n 
pa
rt
ic
le
 s
iz
e,
 d
 [n
m
]
-160
-110
-60
-10
40
90
Ze
ta
 p
ot
en
tia
l, 
ZP
 [m
v]
0
100
200
300
400
500
600
700
0 10 15 22 29 35 49 63 70
time (days)
M
ea
n 
pa
rt
ic
le
 s
iz
e,
 d
 [n
m
]
-160
-110
-60
-10
40
90
Ze
ta
 p
ot
en
tia
l, 
ZP
 [m
V]
 
      a)                                                   b) 
Figure 2 a, b Mean particle size and zeta potential (ZP) after storage of sucrose laureate and 
polysorbate 80 nanoemulsions over an observation period of 10 weeks. Indicated values are 
means (± S.D.) of three experiments. If no bars are shown, phase separation occurred. a) 
polysorbate 80 nanoemulsions: white bars: mean particle size of NT; grey lined bars: mean 
particle size of NT-0.4PS;black bars: mean particle size of NT-0.6PS ;-▲- zeta potential of NT -
X- zeta potential of NT-0.4PS; -●- zeta potential of NT-0.6PS b) sucrose laureate 
nanoemulsions: white bars: mean particle size of NL; grey lined bars: mean particle size of NL-
0.4PS; black bars: mean particle size of NL-0.6PS; -▲- zeta potential of NL; -X-  zeta potential 
of NL-0.4PS; -●-  zeta potential of NL-0.6PS 
 
In contrast phase separation was observed in the sucrose laureate 
nanoemulsion containing 0.4 % PS after 10 days. On the contrary the 
formulation with 0.6 % PS exhibited improved physical stability. However, after 
seven weeks of storage a pronounced particle agglomeration occurred 
simultaneously with a dramatic decrease of the ZP (Fig. 2b, black bars).  
 
3.3. Skin permeation experiments 
 
Firstly, in standard diffusion experiments the skin permeation rates (flux) of the 
model drug fludrocortisone acetate were investigated. As seen in Fig. 3A two 
groups can be distinguished: one group having lower fluxes of fludrocortisone 
acetate is based on the nanoemulsion with sucrose laureate and a second 
group exhibiting higher diffusion rates is based on polysorbate 80 
nanoemulsion. Moreover, PS was able to increase the skin permeation rates of 
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fludrocortisone acetate compared to the control independent of the formulation. 
The addition of 0.6 % PS led to an increase in the permeation rates of 1.5 times 
from sucrose laureate nanoemulsion and 1.4 times of the polysorbate 80 
nanoemulsion compared to the control (Table 3).  
 
Table 3 
Skin permeation rates (flux) of fludrocortisone acetate and flumethasone 
pivalate in different nanoemulsions and influence of phytosphingosine (PS) 
through porcine skin, n=3. (* indicate a statistical significance, p < 0.05) 
Model drug  
 
Nanoemulsion
 
Flux (J, µg/cm²/h) 
Enhancement factor     of 
PS compared to control 
Fludrocortisone acetate NL 0.126±0.027  control  
 NL-0.4PS 0.150±0.010  1.1  
 NL-0.6PS    0.189 ±0.012 *    1.5*  
      
 NT 0.263 ±0.043  control  
 NT-0.4PS    0.353 ±0.018 *    1.3*  
 NT-0.6PS    0.377 ±0.038 *    1.4*  
      
Flumethasone pivalate NT 2.290±0.313  control  
 NT -0.4PS 2.698±0.117  1.18  
  NT -0.6 PS  3.073±0.104*    1.34*   
 
To confirm the influence of PS on the skin rates a set of formulation with the 
polysorbate 80 nanoemulsion containing flumethasone pivalate as other model 
drug was investigated. Again the positive impact of the cationic PS on the flux 
was demonstrated, although to a lesser extent than in the experiments using 
fludrocortisone acetate (Table 3 and Fig. 3B). The enhancement factor for 
flumethasone pivalate by the addition of 0.6 % PS was 1.34.  
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A)        B) 
Figure 3 A-B) Permeation profiles of fludrocortisone acetate (A) and flumethasone pivalate (B) 
incorporated in positively and negatively charged nanoemulsions through porcine skin 
determined by HPLC. Indicated values are means (± S.D.) of three experiments. A) full line:   -●-  
NT-0.6PS; -x-  NT-0.4PS; -▲- NT; dashed line  - - ● - -  NL-0.6PS; - - x - -  NL-0.4PS, - -▲- -   
NL; B) dashed line ─ ─ ● ─ ─ NT-0.6PS; ─ ─ x ─ ─  NT-0.4PS; ─ ─ ▲─ ─ NT  
 
3.4. Differential scanning calorimetry 
To further explore the effect of different nanoemulsions on lipid components of 
porcine skin DSC studies were conducted. All samples were taken from the 
same piece of porcine skin. In literature data it was proposed that porcine 
transitions occurred near 60°, 70° and 100°C in hydrated samples, which were 
due to intercellular lipid, protein-intercellular lipid and keratin, respectively 
(Potts, 1989; Valenta et al., 2001; Kim et al., 2008). In our case porcine skin 
pre-impregnated with water for 12 h showed an endothermic transition peak Tm 
occurring near 80°C.  The pre-impregnation of porcine skin with differently 
charged nanoemulsions resulted in a slight difference of Tm (Fig. 4 and Table 4). 
The maximal thermal transition is shifted from about 80°C to 74°C after 
treatment with negatively charged nanoemulsions independent of the non-ionic 
surfactant. Impregnation of porcine skin with positively charged nanoemulsions 
resulted in a Tm shift from 80°C to 76°C with the polysorbate 80 containing 
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nanoemulsion, whereas no influence of the positively charged sucrose laureate  
nanoemulsion was observed. 
 
Table 4 Thermal changes following pre-impregnation of porcine skin with 
positively and negatively charged nanoemulsions. Control: porcine skin pre-
impregnated with water for 12 h, n≥4 
Treatment    DSC Tm (°C) Linear Onset (°C) 
Control  80.01 ±0.45    65.29 ±0.20 
NL  74.38 ±4.53    65.54 ±5.17 
NL-0.6PS  80.66 ±0.31    64.14 ±0.19 
NT  74.90 ±2.95    64.47 ±2.72 
NT-0.6PS   76.85 ±3.81    66.52 ±2.35 
a Temperature of the transitions maximum Tm 
 
 
 
 
 
  
 
 
 
 
 
Figure 4 Differential scanning calorimetry (DSC) analysis of porcine skin treated with negatively 
and positively charged nanoemulsions. Gravimetric analysis of the samples prior to DSC 
studies showed average water content of about 73% (w/w). Graphs are representative of n≥4 
replicate samples. 
 
 
4. Discussion  
 
This study investigated differently charged nanoemulsions containing either 
sucrose laureate or polysorbate 80 in terms of particle size and zeta potential. It 
is known that non-ionic surfactants stabilise emulsion due to a strong steric 
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repulsion mechanism (Piemi et al.,1999). As the results indicate polysorbate 80 
improved the physicochemical stability of the formulation in comparison to the 
sucrose laureate nanoemulsions. Due to ethylene oxide groups and the long 
hydrocarbon chain a stronger steric stabilisation effect can be achieved. 
Therefore mean particle size and zeta potential values of the polysorbate 80 
containing nanoemulsions were physically stable over 10 weeks showing no 
flocculation, creaming, coalescence and Ostwald ripening. 
Additionally we tested the hypothesis that PS, a known sphingoid base, can 
increase skin permeability by its cationic charge on the negatively charged skin 
(Yilmaz and Borchert, 2005). The obtained data confirmed the pH dependent 
physicochemical properties of the tested PS nanoemulsion. The electrical 
surface charge of the particles is produced by ionisation of PS forming an 
interfacial film. It depends mainly on the extent of the ionisation of PS         
(Fig.1 a, b).  
Percutaneous penetration implies several steps. The release of a drug through 
skin will depend on the physicochemical properties of the drug itself combined 
with the influence of the vehicle to alter the drug penetration profile (Piemi et al., 
1999; Cazares-Delgadillo et al., 2005). The positively charged nanoemulsions 
containing PS were found to be more effective in terms of skin diffusion of 
fludrocortisone acetate and flumethasone pivalate through porcine skin than the 
negatively charged ones (Table 3 and Fig. 3A-B).  
As mentioned the interaction of nanoemulsions with skin depends upon a 
number of factors including also the electrical charge of the droplets. The 
results obtained suggest that positively charged particles of the nanoemulsion 
systems are able to carry efficiently fludrocortisone acetate and flumethasone 
pivalate into the skin and subsequently promote the penetration of the drugs 
through skin. The degree of skin binding is probably more important with the 
positively charged particles than with the negatively one as it is known that the 
skin is negatively charged at neutral pH (Conrads and Zahn, 1987). This 
hypothesis is supported additionally by the results of Piemi et al, 1999. It can 
therefore be deduced that the binding of the charged particles to the skin can be 
attributed to a specific electrostatic interaction due to the positive charge of the 
particles in case of the phytosphingosine containing nanoemulsions (Piemi et 
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al., 1999). Nevertheless, more penetration studies need to be performed to 
confirm the influence of the charge of the vehicle and the binding skin process, 
especially in the case of positively or negatively charged nanoemulsions in 
order to establish a possible structure-binding relationship.  
Moreover the penetration enhancement of drugs is closely related to the nature 
of the surfactants used in the formulation. Many penetration enhancers are 
capable of inserting themselves between the hydrophobic tails of the bilayer, 
thus disturbing their packing, increasing their fluidity, and subsequently, leading 
to an easier diffusion of lipid penetrants. Sucrose laureate interferes with their 
long hydrocarbon chain between the lipophilic tails allowing the sucrose ring to 
interact with the polar lipid head groups (Calderilla-Fajardo et al., 2006). There 
are two possible mechanisms of penetration enhancement suggested for 
polysorbate 80. On one hand it penetrates into the intercellular regions of 
stratum corneum, increases fluidity and eventually solubilises and extracts lipid 
components, and on the other hand an interaction and binding with keratin 
filaments may result in a disruption within the corneocytes. In this case keratin 
filaments and their associated water molecules could be disrupted, whereas a 
solubilising ability of the aqueous layer could result and an allowed drug 
transport through the corneocytes might be possible (Nokhodchi et al., 2003). 
Consequently one reason for the improved skin permeation of fludrocortisone 
acetate caused by using polysorbate 80 will be the protein domains involved.  
In DSC-studies a slight difference was observed between the skin samples pre-
impregnated with differently charged nanoemulsions and the water-impregnated 
control. The decreased transition temperatures showed an interaction with 
lamellar skin lipids structure at temperature near 60-80°C indicating a higher 
fluidity of skin. Due to the higher skin permeation of PS containing 
nanoemulsions we expected a further shift of the transition temperature to lower 
values. However the opposite was observed (Tab. 4). Therefore, the higher skin 
permeation might be caused by additional other mechanisms than by skin lipid 
interactions. It is also known that the water content plays a major role in the 
transition temperature of lipids and proteins  (Potts, 1989). For that reason        
it was seen to it that all samples had equal water content prior to                  
DSC-measurements.  
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5. Conclusion 
 
Overall, we succeeded in creating nanoemulsions with the skin friendly mild 
surfactant sucrose laureate and in enhancing the skin fluxes of the model drug 
fludrocortisone acetate and flumethasone pivalate with PS. In addition the 
nanoemulsion with conventional polyoxyethylene derivatives exhibited higher 
diffusion rates and a prolonged physicochemical stability. Furthermore PS is an 
interesting multifunctional additive for drug delivery systems due to its 
enhancement effect on skin permeation and above all its hydrating and         
anti-inflammatory power.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publications 77
 
6. References  
 
Calderilla-Fajardo, S.B., Cazares-Delgadillo, J., Villalobos-Garcia, R., 
Quintanar-Guerrero, D., Ganem-Quintanar, A., 2006. Influence of sucrose 
esters on the in vivo percutaneous penetration of octyl methoxycinnamate 
formulated in nanocapsules, nanoemulsion and emulsion. Drug Dev. Ind. 
Pharm., 32, 107-113. 
 
Cazares-Delgadillo, J., Naik, A., Kalia, Y.N., Quintanar-Guerrero, D., Ganem-
Quintanar, A., 2005. Skin permeation enhancement by sucrose esters: A pH-
dependent phenomenon. Int. J. Pharm., 297, 204-212. 
 
Cisternino S., Schlatter, J., Saulnier, J.L., 2003. Stability of Fludrocortisone-
acetate solutions prepared from tablets and powder. Eur. J. Pharm. Biopharm., 
55, 209-213. 
 
Conrads A. and Zahn H., 1987. A study of the interaction of sodium dodecyl 
sulphate with the proteins of human heel stratum corneum, Int. J. Cosm. Sci. 
9(1), 29-46 
 
Farwick, M., Watson, R. E. B., Rawlings, A.V., Wollenweber, U., Lersch, P., 
Bowden, J.J., Bastrilles J.Y., Griffiths C.E.M., 2007. Salicyloly-
phytosphingosine: a novel agent for the repair of photoaged skin. Int. J. 
Cosmetics Sci., 29, 319-329. 
  
Fiume, Z., 2001.  Final report on the safety assessment of lecithin and 
hydrogenated lecithin. Int. J. Toxicology, 20, 21-45. 
 
Hoeller S. and Valenta C., 2007. Effect of selected fluorinated drugs in a 
"ringing" gel on Rheological behaviour and skin permeation, Eur. J. Pharm. 
Biopharm., 66 ,120-126. 
 
Kelmann, R. G., Kuminek, G., Teixeira H.F., Koester L.S., 2007. 
Publications 78
 
Carbamazepine parenteral nanoemulsions prepared by spontaneous 
emulsification process. Int. J. Pharm., 342, 231-239. 
Kim, Y.-C., Park, J.-H., Ludovice P.J., Prausnitz, M.R., 2008. Synergistic 
enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int. J. 
Pharm., 352, 129-138. 
 
Müller, R. H., 1996. Zetapotential und Partikelladung in der Laborpraxis. 
Paperback APV, Band 37,Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 
 
Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., 
Barzegar-Jalali M., 2003. The enhancement effect of surfactants on the 
penetration of lorazepam through rat skin. Int. J. Pharm., 250, 359-369. 
 
Paolino D., Ventura, C.A., Nistico, S., Puglisi, G., Fresta M., 2002. Lecithin 
microemulsions for the topical administration of ketoprofen: percutaneous 
adsorption through human skin and in vivo human skin tolerability. Int. J. 
Pharm., 244, 21-31. 
 
Piemi, M. P. Y., Korner, D., Benita, S., Marty, J.P., 1999. Positively and 
negatively charged submicron emulsions for enhanced topical delivery of 
antifungal drugs. J. Contr. Rel., 58, 177-187. 
  
Potts, R. O. 1989. Physical characterization of the stratum corneum: The 
relationship of mechanical and barrier properties to lipid protein structure. In. 
Hadgraft, J.; Guy, R.H. (Eds). Transdermal Drug Delivery.: pp. 23-57. 
  
Sonneville-Aubrun, O., Simonnet, J.T., L´ Alloret, F., 2004. Nanoemulsions: a 
new vehicle for skincare products. Adv. Colloid Interface Sci., 108-109, 145-
149. 
  
Tadros, T., Izquierdo, P., Esquena, J., Solans, C., 2004. Formation and stability 
of nano-emulsions. Adv. Colloid Interface Sci., 108-109, 303-318. 
 
Publications 79
 
Valenta, C., Nowak M., Hadgraft, J., 2001. Influence of phloretin and 6-
ketocholestanol on the permeation of progesterone through porcine skin. Int. J. 
Pharm., 217, 79-86. 
  
Valenta, C., Siman, U., Kratzel, M., Hadgraft, J., 2000. The dermal delivery of 
lignocaine: influence of ion pairing. Int. J. Pharm., 197, 77-85. 
 
Yilmaz E. and Borchert H.-H., 2005. Design of a phytosphingosine-containing, 
positively-charge nanoemulsion as a colloidal carrier system for dermal 
application of ceramides. Eur. J. Pharm. Biopharm., 60, 91-98. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publications 80
 
4.4 Multinuclear NMR characterisation and dermal delivery of fluorinated    
drugs in soybean-microemulsion systems 
 
Sonja Hoeller1, Hanspeter Kählig2, Claudia Valenta3 
J. Pharm. Sci.  in press 
 
1Department of Pharmaceutical Technology and Biopharmaceutics 
University of Vienna, Faculty of Life Sciences 
Althanstrasse 14 
1090 Vienna 
AUSTRIA 
 
2Institute of Organic Chemistry 
University of Vienna, Faculty of Chemistry 
Währinger Str. 38 
1090 Vienna 
AUSTRIA 
3Corresponding Author: Claudia Valenta 
Department of Pharmaceutical Technology and Biopharmaceutics 
Faculty of Life Sciences  
Althanstrasse 14 
1090 Vienna 
AUSTRIA 
 
E-mail: claudia.valenta@univie.ac.at 
Tel: +43 1 4277 55 410 
Fax: +43 1 4277 9554 
 
 
Publications 81
 
Abstract 
 
The present study evaluated the effect of different commercially available 
soybean lecithins in microemulsion systems in terms of microstructure 
transformation, physicochemical properties and transport of selected entrapped 
fluorinated drugs through skin.  
Physicochemical characterisations by particle size and polydispersity index 
(PDI) measurements were performed and a direct correlation with NMR self-
diffusion coefficients of the individual components was found. An increase of 
lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE) and 
lysophosphatidylethanolamine (LPE) in the phospholipid mixtures increased the 
mean particle sizes and PDI. Bicontinous microemulsion structures were proven 
by 1H and 31P NMR in the placebo microemulsions. Reasonable permeation of 
the lipophilic drugs of all microemulsions systems was confirmed in standard 
diffusion studies using porcine skin.  This could be due to the incorporation of 
the drugs in the surfactant structure of the lecithin based bicontinous micro 
textures, as proven by 19F NMR self-diffusion studies.  
 
Keywords: 1H NMR, 19F NMR, 31P NMR, skin permeation, microemulsion, 
phospholipid 
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1. Introduction 
 
Liquid crystalline, micellar and emulsion forming systems are widely used in 
pharmaceutical preparations. The easy formation and excellent solubilisation 
capacity favour microemulsions over other pharmaceutically used systems. The 
dispersed phase, lipophilic or hydrophilic (o/w, w/o or bicontinuos type) can act 
as a potential reservoir of lipophilic or hydrophilic drugs which are partitioned 
between the dispersed and the continuous phase 1.   
A disadvantage of microemulsions is their relatively high concentration of 
surfactant and the requirement need for the presence of a co-surfactant. The 
potential of a topical formulation to be used as a transdermal drug delivery 
device should be evaluated not only in terms of carrier capacity and 
percutaneous drug absorption, but also in terms of tolerability and toxicity of the 
proposed formulation 2. Therefore, the microemulsion components in the 
present study were chosen according to their biocompatibility and toxicity in 
order to produce highly eudermic formulations.   
Microemulsions stabilised by lecithins will be highly regarded as potential 
delivery vehicles, since lecithin is a natural surfactant with a strong ability to 
adsorb on biomembranes and to enhance biomembrane permeability 3. 
Moreover, lecithins are found generally to be non-irritating and non-sensitising 
for human skin 4.  Lecithin exhibits a very strong hydrophobicity due to long 
hydrocarbon chains as well as a strong hydrophilicity due to the zwitterionic 
polar head groups, which have dipole moments. There is a close balance 
between hydrophilic and lipophilic properties 5. To obtain optically clear 
microemulsions using lecithin as surfactant a short chained alcohol is needed 
as a co-surfactant 6. Therefore, isopropanol was used. The permeation 
enhancer isopropylmyristate (IPM), which usually has no irritating effects and 
good dermal compatibility, was used, as oily phase. 
The drug release kinetics depend on their structure (droplet size, volume 
fraction of the dispersed phase etc.) as well as on many other physicochemical 
factors such as the solubility of the drug in both media, the properties of 
interfacial layers of surfactants, interfacial tension etc. 7. Therefore, the choice 
of an appropriate vehicle to maximise skin permeation is necessary.  
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Phospholipid-based formulations are known to improve the permeation efficacy 
of active molecules. The entrapment of lipids strongly affects the microemulsion 
structures and the locus of the drug on interface 8. Also, the compositions of 
commercially available lecithins may affect the microstructure and thus the 
permeation of the incorporated drugs 9. In this study we are therefore evaluating 
the physical properties of microemulsion systems containing different 
commercially available soybean lecithins regarding their phosphatidylcholine 
content, their composition and their capability to transport different entrapped 
lipophilic drugs through the skin. In order to evaluate the microstructure the 
resulting systems should also be characterised by generating self-diffusion 
coefficients of the individual components of the vehicle by 1H and 31P NMR. 
Moreover 19F NMR should be used for measuring the self-diffusion of the low 
concentrated fluorinated drugs and, if possible, should be related to the skin 
permeation. 
 
2. Material and methods 
 
2.1. Materials 
 
Fluconazole (CAS: 86386-73-4), flufenamic acid (CAS: 530-78-8), flutamide 
(CAS: 13311-84-7) and flumethasone pivalate (CAS: 2002-29-1) were 
purchased from Kemprotec (UK). Lipoid S100, Lipoid S75 and Lipoid S45 were 
kindly donated by Lipoid GmbH (Ludwigshafen, Germany). Isopropanol (IP) was 
supplied by Merck (Hohenbrunn, Germany). Isopropylmyristate (IPM) was 
purchased from Sigma-Aldrich (St.Louis, USA).  
 
2.2 Formulations 
 
The oily phase consisting of lecithin and IPM was mixed with the co-surfactant 
isopropanol and water was added gradually under magnetic stirring at room 
temperature until the system was transparent. The components of the 
commercially available lecithins are listed in Table 1.  The microemulsions  
consisted of 25% IPM, 25% isopropanol, 25% water and 25% Lipoid S100 (A),  
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Lipoid S75 (B) and Lipoid S45 (C) respectively (each % w/w, Table 2). The 
fluorinated drugs fluconazole, flumethasone pivalate, flutamide and flufenamic 
acid (each 1% w/w) were solved in the oily phase and thereby incorporated into 
the systems.  
 
Table 1 Compositions of the main components within the different soybean-
lecithins 
Lecithina PC LPC PE LPE 
 % 
(w/w)b 
% 
(mol)c
% 
(w/w)b
% 
(mol)c
% 
(w/w)b
% 
(mol)c 
% 
(w/w)b 
% 
(mol)c
Lipoid S 100 98.00 100 0.70 0.8 < 0.1 - - - 
Lipoid S 75 72.70 100 1.80 3.3 8.50 12.9 - 3.7 
Lipoid S 45 48.80 100 1.60 3.9 15.40 34.9 - 7.4 
 a Abbreviations: PC = phosphatidylcholine, LPC = lysophosphatidylcholine, PE = 
phosphatidylethanolamine, LPE = lysophosphatidylethanolamine; b as supplied by the 
manufacturer; c Integration values of the 31P NMR spectra, relative to PC 
 
 
Table 2 Compositions of the microemulsions in % (w/w) 
              Microemulsions  
  A B C 
Isopropylmyristate 25.0 25.00 25.00
Lipoid S100 25.0 -- -- 
Lipoid S 75 -- 25.00 -- 
Lipoid S 45 -- -- 25.00
Isopropanol 25.0 25.00 25.00
Water 25.0 25.00 25.00
 
 
2.3 Characterisation and physical stability of the microemulsions 
 
Microscopic observation to characterise the structure of the microemulsion 
systems were made using an optical polarising microscope. The mean particle 
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size and polydispersity index (PDI) were estimated by photon correlation 
spectroscopy with a Zetasizer Nano ZS (Malvern, UK) at 25°C. The 
measurements were performed using a He-Ne laser at 633 nm. The diameters 
were determined after microemulsions preparation and were checked over 10 
weeks during storage at room temperature. 
The viscosity of the placebo microemulsions was measured using a Haake 
MARS Rheometer with a plate/plate (PP60/Ti). Flow curves were performed at 
the following parameters: controlled rate (CR) modus, ץ= 1-100; 25°C ±0.2°C.  
  
2.4 NMR measurements  
 
NMR experiments were performed on a BRUKER Avance DRX 600 NMR 
spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) operating at 
600.13 MHz for 1H, 564.69 MHz for 19F, and 242.94 MHz for 31P, respectively. 
Either a 5 mm triple inverse probe (1H, 13C, broadband) with triple axis gradient 
coils was used or a 5 mm quadruple observe probe (1H, 13C, 19F, 31P) with z-
axis gradient coil. For spectrometer stability reasons the H2O phase in the 
microemulsions was replaced by D2O. The diffusion coefficients at a constant 
temperature of 25°C were derived from the signal attenuation in a series of 
stimulated echo spectra with increasing gradient amplitudes by fixed diffusion 
delay according to Wu et al. 10. To overcome thermal convection effects, either 
only orthogonal gradients were used or the sample tubes were rotated 11. 
Typical experimental parameters were chosen as in the reference 12.  
Heteronuclear diffusion coefficients were measured with a similar experimental 
setup using the following parameters: for 19F the individual signals were set on 
resonance, the sweep width to 5.6 kHz, the time domain to 22000 data points, 
the relaxation delay to 5 s, and the number of scans to 8; for 31P the sweep 
width was set to 4.8 kHz, the time domain to 29000 data points, the relaxation 
delay to 5 s, and the number of scans to 16. To collapse the proton coupling in 
the 19F as well as in the 31P NMR spectra, WALTZ-16 composite pulse 
decoupling was performed during acquisition with a γB1 of 1 kHz. For 19F NMR, 
CCl3F (δ = 0 ppm), for 31P 85% H3PO4 (δ = 0 ppm) was used as external 
reference, respectively. The processing and the analysis of the self-diffusion 
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measurements were done within the Topspin Software, Version 2.1 (Bruker 
BioSpin, GmbH, Rheinstetten, Germany). For the diffusion ordered 
spectroscopy (DOSY) representation, all Fourier transformed spectra of the 
stimulated echo series were fitted independently using a Levenberg-Marquardt 
algorithm. All experiments were repeated at least 5 times, the accuracy was 
±4%. 
 
2.5 In vitro permeation studies 
 
Porcine abdominal skin was shaved and prepared with a dermatome (GB 228R, 
Aesculap) set at 1.2 mm. The skin was stored in a freezer at -20°C until use. 
Two hours prior to the experiment the samples were thawed. 
Standard diffusion experiments using the same protocol and HPLC analysis for 
all drugs were performed as recently reported 13. Briefly, the diffusion cells were 
thermostated at skin surface temperature of 32°C and stirred by magnetic bars 
for 8h. Samples of 200 µl were removed at defined time intervals (2, 4, 6, and 
8h) for analysis and replaced by fresh receptor medium. Minimum three parallel 
experiments were performed.  
 
2.6 Statistics 
 
For statistical data analysis of Tables 3 and 7 the non parametric Kruskal-Wallis 
Test was performed with p<0.05 as a minimal level of significance. Results are 
expressed as the mean of at least four parallel experiments ± S.D. 
 
3. Results and Discussion 
 
3.1 Formulations  
 
Much attention has been paid on phospholipid-based microemulsions and their 
pharmaceutically acceptability, recently 14. Their non-toxicity makes them an 
ideal choice for dermal and transdermal drug delivery. All formulations were 
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formed spontaneously, their appearance being of a transparent homogenous 
yellow liquid.  
 
3.2 Characterisation of the microemulsions 
 
All investigated formulations showed black isotropic textures under polarized 
light microscope.  This indicates a microemulsion system and no liquid 
crystalline phase, which appears under the microscope with characteristic 
coloured textures15. In the first part of the work the influence of different 
soybean lecithins on the physicochemical properties of the microemulsions was 
analysed. Droplet diameter in stable microemulsions is usually within the range 
of 10-100 nm, which means that the term “microemulsion” maybe misleading 
and these systems are actually nano-sized systems 16. As shown in Table 3, all 
investigated microemulsions are characterised by a very small droplet size. The 
mean particle size was less then 10 nm and the polydispersity index (PDI) 
obtained values under 0.2 in each formulation, which indicates a close size 
distribution providing good stability 17. A smaller content of PC, but higher 
content of phosphatidylethanolamine (PE) led to an increase in the mean 
particle size, which might be a consequence of the different microstructures 
caused by the different soybean lecithins used in the systems.  In addition, the 
incorporated drug can take part in the microstructure of the system, thus 
influencing the microemulsion arrangement and properties via molecular 
interaction, as seen in Table 2 2.  In order to investigate the influence of the 
different lecithin composition the viscosity of the placebo formulations was 
measured. All investigated formulations showed ideal newton`sche flow curves 
(data not shown) 15. As expected, the viscosity depended on the lecithin 
composition and was 11.05 ±4.4 mPas (A), 16.35 ±2.7 mPas (B) and 17.06 
±1.7 mPas (C).  
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Table 3 Mean particle size (d.nm) and polydispersity index (PDI) of the tested 
microemulsions (*significant different to  
 
Microemulsion Placebo Flufenamic Flumethasone Flutamide Fluconazole
    acid pivalate     
  Size d.nma Size d.nma Size d.nma Size d.nma Size d.nma
A 1.34±0.02 1.56±0.16 1.12±0.02 1.06±0.01 0.77±0.03
B 1.26±0.03 1.39±0.04 1.12±0.02 1.07±0.04 1.40±0.06
C  2.25±0.14*  3.72±0.31*  1.71±0.10*  1.62±0.05*  2.19±0.05*
  PDIb PDIb PDIb PDIb PDIb 
A 0.05-0.30 0.05-0.21 0.08-0.33 0.07-045    0.21-0.5 
B 0.09-0.33 0.03-0.24 0.10-0.46 0.11-0.4 0.06-0.22 
C 0.13-0.33 0.04-0.36 0.12-0.5 0.01-0.21 0.05-0.34 
a average over 10 weeks of measurements, n=30 
b average over 10 weeks of measurements, n=30 
 
3.3  NMR 
 
A multinuclear NMR approach was chosen for analysing the phospholipid-
based microemulsions alone as well as the drug loaded formulations. First the 
variations in the different lipoids were studied by 31P NMR. The main 
phosphorous containing components give characteristic resonance lines in the 
31P NMR spectra (Fig. 1). The assignment is based on the literature 18, or on 1H 
coupled 31P NMR spectra (not shown). Due to the 1H-31P scalar coupling small 
amounts of phosphatidic acid can be identified by a triplet splitting, were all the 
other components show quintet signals. Using the same approach, 
phosphatidylinositol, another common constituent of soybean lecithins, can be 
excluded, which should show a quartet splitting. The amounts of the main 
components within the different soybean lecithins are listed in Table 1. The first 
row presents the % (w/w) of the phospholipids within the total lecithin 
preparations as given by the supplier, the second the relative mol percentages 
calculated from the integrated 31P NMR spectra setting the phosphatidylcholine 
(PC) to 100%, respectively. This information is more feasible for the present 
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study delivering the relative proportion of the most prominent phospholipids in 
the individual lecithins. Going in the series from lipoid S100 to S45, the overall 
amount of PC is reduced, increasing at the same time the 
phosphatidylethanolamine (PE) as well as the lyso-form of PE. Whereas lipoid 
S100 is almost quantitatively PC, the molar ratio of PC to PE is about 9 to 1 in 
lipoid S75, going to 3 to 1 in lipoid S45. 
 
 
Figure 1 31P NMR of microemulsions A, B, and C (PC phosphatidylcholine, PE 
phosphatidylethanolamine, LPC lysophosphatidylcholine, LPE lysophosphatidylethanolamine, 
PA phosphatidic acid) 
 
The next step was the characterisation of the microemulsion carrier systems by 
NMR self-diffusion experiments. The discrimination between the individual 
components is possible based on characteristic resonance lines in the well 
resolved 1H NMR spectra (Fig. 2, top spectrum), namely the HDO signal (4.97 
ppm) for the water, the CH (4.19 ppm) or CH3 (1.39 ppm) signal for isopropanol, 
the alcohol CH (5.18 ppm) or CH3 (1.42 ppm) or the CH2 (2.43 ppm) adjacent to 
the ester group for isopropylmyristate (IPM), and mainly the trimethylamino 
resonance (3.48 ppm) of phosphatidylcholine for the lecithins. The diffusion 
ordered spectrum (DOSY) of microemulsion A is shown in Fig. 2. In this 
representation the series of the Fourier transformed stimulated echo spectra 
were fitted independently resulting in a two dimensional data matrix with the full 
spectral information for every compound on one axis separated by the 
corresponding diffusion coefficient on the other. As can be seen in Fig. 2, the 
individual components are spread over the diffusion axis giving well resolved 
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single rows for water, oil and surfactant as well as for the co-surfactant at the 
appropriate diffusion constants. The ability of resolving multi-exponential decays 
in this representation should not be overestimated as can be seen especially in 
the region of the overlapping aliphatic chains of PC and IPM. Nevertheless 
discrete self-diffusion coefficients for all components can be calculated from 
undisturbed resonances using a linear least-squares approach.  
 
 
Figure 2 DOSY (1H Diffusion Ordered Spectroscopy) of microemulsion A with 1H NMR spectrum 
as top trace (IP isopropanol, IPM isopropylmyristate, PC phosphatidylcholine) 
 
In Table 4 these diffusion coefficients D in the three formulations are 
summarized, together with the values for the neat solvents D0. In the case of 
water, the observed experimental values have to be corrected due to exchange 
contributions mainly with the co-surfactant isopropanol 19. The diffusion 
behaviour of water, oil, and surfactant system looks very similar in the three 
different formulations, overall only a small slowdown for all constituents is 
observed going from microemulsion A over B to C. Thus the NMR diffusion data 
are in good agreement with photon correlation spectroscopy in this formulation 
series (Table 3) showing an increased particle size as well as an increased 
polydispersity index following the same order of the vehicles. 
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Table 4 NMR Self-diffusion coefficients for the individual components neat and 
in the three formulations from 1H or 31P NMR (for PC and PE) experiments 
 neat A B C 
 D0 [m2s-1]b D [m2s-1] D/D0 D [m2s-1] D/D0 D [m2s-1] D/D0 
Water 1.90x10-9 3.00x10-10 0.16 2.50x10-10 0.13 2.38x10-10 0.12 
IPa 5.40x10-10 2.30x10-10 0.42 2.16x10-10 0.40 2.15x10-10 0.40 
IPM 2.11x10-10 1.15x10-10 0.54 1.09x10-10 0.51 1.08x10-10 0.51 
PC 
(1H)1 
3.43x10-10 2.70x10-11  2.22x10-11  2.18x10-11  
PC (31P)  2.71x10-11  2.25x10-11  2.26x10-11  
PE (31P)  -  2.26x10-11  2.20x10-11  
a Abbreviations: IP = isopropanol, IPM = isopropylmyristate, PC = phosphatidylcholine, PE = 
phosphatidylethanolamine; b D0 for PC 0.3 % (w/w) in MeOH-d4 
 
To gain further insight into the diffusion of the phospholipids, additional NMR 
diffusion experiments were performed on the phosphorous frequency to 
discriminate between the phosphatidylcholine and phosphatidylethanolamine 
signals. However, the measured self-diffusion coefficients are within the 
experimental error almost the same for PC and PE and comparable with the 
values derived from 1H NMR. This behaviour could be expected due to their 
similar molecular weight, but can on the other hand not be taken for granted 
within a high concentrated multi component system. So both phospholipids 
seem to be incorporated in a similar structural surrounding within the 
microemulsions. The lyso-forms of PC and PE could not be analysed by 31P 
NMR diffusion spectra, as the signal to noise ratio for these low concentrated 
constituents is not sufficient for a reliable fitting of their diffusion decays.  
The detailed analysis of the NMR derived self-diffusion coefficients (Table 4) for 
water and oil results in high values for both, which are in the same order of 
magnitude, thus indicating a non discrete particle system. The diffusion of 
lecithin is found to be slow, far below the molecular level, which was measured 
as reference for solutions of the three lipoids in deuterated methanol below the 
critical micelle concentration 20. Taking these results together, on the one hand 
the fast diffusion of water and oil and on the other the one order of magnitude 
lower surfactant diffusion, a bicontinuous microemulsion can be concluded 22. 
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Calculating relative or normalized diffusion coefficients Drel, the microstructure 
of the three formulations can be further evaluated. They are given by the 
fractions D/D0, thereby D0 being the diffusion coefficient of the neat and D of the 
component within the microemulsion, respectively. For isopropylmyristate Drel 
with 0.54 to 0.51 in the three formulations seems to be suitable for layered 
structures. With a hindered diffusion in one and free in the two other directions 
Drel should be 2/3 in an ideal layering. The observed values are somewhat 
reduced for IPM, but very much lowered for water with Drel 0.16 for formulation 
A to 0.12 for C. Thus other factors than microstructure have to be taken into 
account resulting in a pronounced reduction of the diffusion coefficients, namely 
solvation and hydration. Both become very significant at high surfactant 
concentrations 21. In addition the investigated microemulsions contain high 
amounts of the co-surfactant isopropanol, defining together with water the polar 
domain. The high alcohol content decreases the polarity of the polar medium 
significantly. With a Drel around 0.41 the diffusion is significantly different 
compared to pure IP, so it seems be incorporated to a certain extend in the lipid 
layers. The interactions of water with the surfactant mixture, as for hydration, 
the strong polar headgroup coupling to the phospholipids, and as for the 
cosurfactant, the high solubility of water in isopropanol, can be summarized as 
an explanation for the rather low observed diffusion of water in the 
microemulsion systems. 
The drug loaded formulations were also investigated by NMR self-diffusion 
experiments. They contain 1 % (w/w) of flufenamic acid, flumethasone pivalate, 
flutamide, or fluconazole in the same above described carrier systems. As can 
be seen from the diffusion data of drug loaded microemulsion A (Table 5), all 
diffusion coefficients are reduced, most pronounced for the isopropylmyristate. 
The same reduction is found in a similar manner for the two other formulations 
B and C. This observation may be explained by small irregularities in the 
structure induced by the addition of the drugs, thereby reducing the D values 
significantly 22. Drel = 0.34 for IPM in the drug loaded versus 0.54 in the 
unloaded system would be consistent with proposed models in the literature, 
e.g. a changeover from a layered to a more tubular type bicontinuous 
microemulsion 21.  
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Table 5 NMR Self-diffusion coefficients for the individual components in the 
drug loaded microemulsion A 
 Flufenamic acid Flumethasone 
pivalate 
Flutamide Fluconazole 
 D [m2s-1] D/D0 D [m2s-1] D/D0 D [m2s-1] D/D0 D [m2s-1] D/D0 
Water 2.00x10-10 0.11 2.10x10-10 0.11 2.04x10-10 0.11 2.08x10-10 0.11 
IP 1.50x10-10 0.28 1.51x10-10 0.28 1.54x10-10 0.29 1.51x10-10 0.28 
IPM 7.20x10-11 0.34 7.26x10-11 0.34 7.39x10-11 0.35 7.24x10-11 0.34 
PC 1.65x10-11  1.80x10-11  1.76x10-11  1.71x10-11  
 
The last missing parameter is the diffusion of the drugs in the vehicles. In this 
case, 1H NMR self-diffusion experiments are very unfavourable, as the 
concentration of the drug is only 1% w/w, resulting in dynamic range problems 
of the receiver and poor signal to noise ratios for the drug signals. Nevertheless 
it has been successfully demonstrated recently for steroid hormones in 
eucalyptus oil based microemulsions 23. In the present study, fluorine containing 
compounds were chosen having with the 19F isotope a very sensitive NMR 
probe suitable for self-diffusion studies. This approach is very promising, as 
already about 20% of the pharmaceuticals on the market contain fluorine 24. 19F 
NMR alleviates most of the problems encountered with 1H observation, e.g. 
signal overlap or dynamic range problems. Additionally, the 19F nucleus has 
100% natural abundance and a magnetogyric ratio almost like 1H. Performing 
stimulated echo experiments on the fluorine frequency by altering the gradient 
amplitude results in signal decays with a high signal to noise ratio, very well 
suitable for fitting the self-diffusion coefficients (Fig. 3). Flufenamic acid and 
flutamide exhibit a CF3 group with a chemical shift of -64.68 ppm and -62.10 
ppm, respectively. The two other compounds contain two fluorine atoms, both 
can be used for the diffusion studies. Fluconazole has a difluoro-substituted 
aromatic ring (-109.52 ppm, -112.66 ppm), flumethasone pivalate has two 
fluorines in the steroidal positions 6 and 8 (-189.01 ppm, -166.19 ppm).  
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Figure 3 Experimental echo decay for the fluorinated drugs in microemulsion A as measured by 
19F diffusion NMR (▲, flumethasone pivalate; ?, fluconazole; ? flufenamic acid; ?, flutamide) 
 
 
The 19F NMR derived self-diffusion coefficients in the three different 
microemulsions are given in Table 6, together with values measured in 0.1% 
w/w solutions in deuterated methanol as reference.  
 
Table 6 19F NMR Self-diffusion coefficients of the drugs in the three 
microemulsions and in 0.1% (w/w) solution of MeOH-d4 
 
 Flufenamic 
acid 
Flumethasone 
pivalate 
Flutamide Fluconazole 
 D [m2s-1] D [m2s-1] D [m2s-1] D [m2s-1] 
A 6.65x10-11 4.26x10-11 7.23x10-11 5.51x10-11 
B 6.59x10-11 3.88x10-11 7.22x10-11 5.46x10-11 
C 6.79x10-11 2.20x10-11 7.16x10-11 4.99x10-11 
MeOH-d4 9.86x10-10 7.28x10-10 1.03x10-9 8.52x10-10 
 
In Figure 4A the diffusion of the four drugs in methanol is plotted against their 
molecular weight. For ideal spherical molecules a reciprocal cube-root 
dependence of the diffusion coefficient on molecular weight is expected at 
infinite low concentration 26. Obviously Fig. 4A displays deviations from the 
proposed model. The diffusion of fluconazole seems to be slowed down 
compared to the three other drugs. If the reason is a non-spherical shape, this 
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behaviour would be more expected for flumethasone pivalate due to the 
extended steroide skeleton. Another explanation for the reduced D value of 
flucanozole could be some kind of molecular association.  As for the drug 
loaded microemulsions, the diffusion of the fluorinated compounds in the three 
vehicles is significantly lowered by one order of magnitude compared to the 
molecular diffusion. The derived D values of the drugs are in the diffusion range 
between isopropylmyristate and lecithin. The line width of 19F NMR signals in 
the formulations is only slightly increased relative to in methanol, upmost by a 
factor of 1.5 in the case of flumethasone pivalate. So the rotational correlation 
time of the drugs seems to be nearly unaffected in the microemulsions, but the 
translational motion is spatially hindered in the bicontinuos structural network 
formed by the lecithins. The individual picture within the drug series looks 
similar compared to the methanolic solutions (Fig. 4B), although on another 
scale. Again, the diffusion of fluconazole is lowered relative to the three others. 
But the most pronounced absolute reduction of the diffusion coefficient can be 
seen for flumethasone pivalate in the phosphatidylethanolamine enriched 
vehicles. For this spatially enlarged structure the molecular displacement 
becomes more hindered in microemulsion B and especially in C, which would 
be consistent with a shift in microstructure to a more tubular type.  
 
 
A 
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B 
 
 
Figure 4 A, B 
A: 19F NMR self-diffusion of the fluorinated drugs in deuterated methanol as a function of the 
molecular weight (MW) 
B: 19F NMR self-diffusion of the fluorinated drugs in the three microemulsions (?, A; ?, B; ▲, 
C) as a function of the molecular weight (MW) 
 
Overall, the incorporation of the drugs in the surfactant structure of the 
microemulsions as proven by 19F NMR self-diffusion studies can be an 
explanation for their good skin permeation within these lecithin based 
formulations, which will be described in the next part. 
 
 
3.4 In vitro permeation studies 
Permeation studies were performed using microemulsion systems consisting of 
different commercially available lecithin surfactants (Table 1) in order to 
evaluate the cumulative amount permeated of selected fluorinated drugs. 
Lecithins can influence the permeability of the skin due to their high affinity for 
epidermal tissue. They are able to mix with lipid components of skin and induce 
a change in skin lipid fluidity, thus leading to an enhanced percutaneous 
absorption of drugs 2. In addition, the lecithin-mediated improvement of 
percutaneous drug absorption can also be elicited by the increased hydration of 
the stratum corneum, determined by various lecithin-based formulations 25. The 
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cumulative amounts permeated of the incorporated drugs after 8 h of diffusion 
time are presented in Table 7. The results show good skin permeation for all 
tested formulations. Drug release appears to be more dependent on the 
structure and interactions of the incorporated drugs than on the lecithin 
composition, as confirmed by the 19F NMR self-diffusion data (Table 6). Though, 
the skin permeation rate seems to be slightly dependent on the lecithin 
composition, but no significance was calculated (Table 7). This might be due to 
hydrophobic interactions between skin and phosphatidylethanolamine, which is 
in good agreement with already published data 9. Though, it was not possible to 
find a direct correlation between the cumulative amount permeated and the self-
diffusion coefficient of the drugs in the vehicle.  
Table 7 Comparison of the cumulative drug amount (µg/cm²) of the fluorinated 
drugs permeated after 8 h of diffusion time through porcine skin, n=4 
 Cumulative drug amount permeated [µg/cm²] 
Microemulsion Flufenamic acid 
Flumethasone  
pivalate Flutamide Fluconazole 
     
A 9.58±6.48 16.78±4.31 2.22±0.84 334.06±40.29 
B 31.17±8.15 29.29±9.00 3.46±0.41 548.3±113.16 
C 27.47±6.37 14.80±2.46 2.70±0.46 299.54±37.05 
 
 
4. Conclusion 
 
These studies demonstrated a direct relationship between droplet size and 
NMR self-diffusion coefficients of the individual components going from 
microemulsion A over B to C. An increase of LPC, PE and LPE in the 
phospholipid mixtures increased the droplet sizes and PDI. The NMR self-
diffusion coefficients indicated a bicontinuous structure. In addition, the 
chemical structure of the incorporated drugs had an impact on the diffusion in 
the microemulsions and an influence on skin diffusion. However, a direct 
correlation was not seen. Due to the slow diffusion of the drugs, as obtained by 
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19F NMR diffusion studies, they were incorporated in lipid bilayers. The insight in 
the physicochemical structure is of great importance to understand the complex 
interactions within the vehicle as well as between skin and vehicle. 
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Abstract 
 
The effect of the anti-inflammatory components phytosphingosine (PS) and N-
palmitoylethanolamine (PEA) on the phase transition and phase properties of 
1,2- diplamitoylphosphatidylcholine (DPPC) as model membrane has been 
investigated. The technique employed to monitor these processes was micro-
differential scanning calorimetry (microDSC) that appears to be particularly 
suitable to follow interactions of active agents with biomembrane models. The 
formulations have been characterised by means of photon-correlation-
spectroscopy after swelling the liposomes with different molar ratios of PS and 
PEA. The mean particle size and polydispersity index (PDI) increased by 
increasing the concentration of PS and PEA, respectively. Moreover, both 
compounds studied altered the main transition temperature of the gel to liquid-
crystalline phase transition and the enthalpy values in the same manner. A 
slight increase of the main phase transition and enthalpies could be observed 
indicating the perturbation of the membrane structure and fluidity. Overall, the 
results obtained give indications of interactions with the model membrane. 
Since skin is also a complex bilayer system, these interactions might be 
important for the use of these naturally occurring and anti-inflammatory 
ingredients in drug delivery systems.   
 
 
Keywords: DPPC-liposomes, Phytosphingosine, N-palmitoylethanolamine, DSC 
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1. Introduction 
 
Dipalmitoylphosphatidylcholine (DPPC) is a typical phospholipid with regard to 
its role in determining the physical-chemical and biological properties of cellular 
membranes. When dispersed in water multilamellar liposomes are 
spontaneously formed having a similarity to biological membranes and are 
therefore used very often as such simple model membranes (Gardikis et al 
2006; Zhao et al 2007). 
 The formed phases from these model membranes with increasing temperature 
have already been described (El Maghraby et al 2005; Gardikis et al 2006; 
Panicker 2008). The main transition from gel-to-liquid crystalline (Pß´?Lα) 
phases is of physiological importance, as in physiological conditions the lipids 
are in their liquid crystalline state in most of the bio-membranes. Therefore any 
alterations in these properties are indicative of the perturbation of the 
membrane structure and fluidity. The interaction of the lipid with exogenous 
molecules in the bilayer, depends on its chemical-physical behaviour and 
concentration (Panicker  2008).  
The free sphingoid base phytosphingosine is naturally found in the human body 
and is present at high levels in the stratum corneum. In recently performed 
studies PS had anti-microbial properties against probionibacterium acnes and 
staphylococcus aureus and therefore effectively reduced the signs of acne. 
Furthermore, additional studies confirmed that PS reduced redness and 
inflamed skin (Yilmaz & Borchert  2005; Yilmaz & Borchert 2006; Kang et al 
2007). Additionally we documented a positive effect on the skin permeation of 
fludrocortisone acetate in nanoemulsion formulations (Hoeller & Valenta 2008; 
Hoeller & Valenta 2008). N-palmitoylethanolamine (PEA) is also a naturally 
occurring lipid found in the human body and isolated from soybean lecithins and 
egg yolk (Lambert et al 2002). Recently cannabinoid receptors have been 
identified on cutaneous sensory nerve fibers binding to endogenous 
cannabinoids such as N-palmitoylethanolamine offering a rational therapeutic 
option for treatment of pruritus (Ständer et al 2006). In a small clinical study (22 
patients) it has been proven that a cream containing PEA was successful in 
treatment of chronical itch (Ständer et al 2006). Moreover another big clinical 
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study (2456 patients) showed substantial relief of objective and subjective 
symptoms of atopic eczema after regular skin care with a PEA cream (Eberlein 
et al 2007). PEA is also of considerable interest because of its properties as 
anti-inflammatory and anti-viral agent (Swamy  et al 2003).  
Phytosphingosine and N-palmitoylethanolamine both are anti-inflammatory 
ingredients with positive effects on skin. Other anti-inflammatory substances 
such as non-steroidal anti-inflammatory drugs have been found to show a 
complex interaction with DPPC liposomes inducing perturbations in the lipid-
crystalline phase suggesting a major change in the hydration behaviour of 
DPPC (Lucio et al 2008). In the current study micro-differential scanning 
calorimetry measurements (microDSC) were applied for the thermoanalysis of 
the phase behaviour of DPPC liposomes and the ability of the naturally 
occurring anti-inflammatory phytosphingosine (PS) and N-
palmitoylethanolamine (PEA) to bind or to penetrate into layers of the surface 
active phospholipids. 
 
2. Materials and Methods 
 
2.1. Materials 
 
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was purchased from 
Lipoid (Switzerland). The product was Lipoid PC 16:0/16:0. According to its 
specification the content of phosphatidylcholine related to the dry weight was at 
least 99 %. Phytosphingosine (PS) was kindly provided by Degussa 
(Cosmoferm BV, NL) and N-palmitoylethanolamine (PEA) was obtained from 
Sanova Pharma GesmbH (Austria). All other chemicals used in this study were 
of analytical reagent grade and were used as received without any further 
purification. 
The chemical structures of phytosphingosine and N-palmitoylethanolamine are 
presented in Fig. 1.  
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Fig. 1 Chemical structure of phytosphingosine and N-palmitoylethanolamine    
 
2.2. Preparation of Liposomes 
 
DPPC liposomes were prepared according to a previous described method 
(Thompson et al 2006). In brief, the phospholipid powders were dispersed in 
deionised water at 60°C and magnetically stirred until the powder was 
completely dissolved and thoroughly mixed using an ultra-Turrax (Omni 500) to 
produce a dispersion with a final phospholipid concentration of 2,5 % (w/w). 
Afterwards the dispersion was homogenised with a high-pressure homogeniser 
(EmulsiFlex-C3, Avestin) for sixteen times at ~ 1100 bar.  
For interaction studies, phytosphingosine and N-palmitoylethanolamine (from 2, 
5 to 10 mol%) were incorporated, respectively, in the liposome structure by 
adding to the liposome dispersion and mechanical swelling for 24 h at 60°C.  
 
 
2.3 Particle size measurement of liposomes   
 
The mean particle size and size distribution were determined by photon 
correlation spectroscopy with a Zetasizer Nano ZS (Malvern, UK) at 25°C. The 
liposomes dispersion was diluted to the appropriate concentration with 
deionised water after 24 h of preparation. The size distribution was represented 
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by the polydispersity index (PDI) values. The measurements were performed 
using a He-Ne laser at 633 nm.  
 
2.4. Micro-Differential scanning calorimetry (microDSC) studies 
 
Thermal scans were performed using a Setaram III micro-calorimetry (n=3 per 
liposome preparation). 0.45 ml of the liposomal dispersion containing an 
average of 11.25 mg DPPC was sealed in a batch cell. The samples were 
analysed by heating at a scanning rate of 1 °C/min over the temperature range 
15-65°C, using deionised water as reference.   
 
2.5. Data analysis 
 
Results are expressed as the means of at least three parallel experiments (± 
S.D.). Thermal transitions were analysed using Setsoft 2000 software. After 
baseline subtraction, raw power data were converted to molar heat capacity 
data. Baselines were fitted to the pre-transition and main transition regions 
using a linear baseline function so that transition temperatures and enthalpies of 
reaction could be calculated for each lipid concentration. 
 
3. Results and Discussion 
 
New anti-inflammatory drugs for safe dermal applications are of great interest, 
because the number of people with atopic eczema and intensely pruritic 
deseases are increasing. Phytosphingosine and N-palmitoylethanolamine might 
be promising candidates for safe application. In case of PS beside the anti-
inflammative an additional penetration enhancing effect on fludrocortisone 
acetate skin permeation was measured (Hoeller & Valenta 2008). Therefore, 
this multifunctional PS could have the benefit of reducing topical corticosteroids 
and acting himself anti-inflammatory. However, the mechanism of action is not 
clearly understood. PEA, another anti-inflammatory agent has already been 
included in one atopic product and has been tested to reduce symptoms of 
atopic eczema after regular skin care (Eberlein et al 2007).  
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Therefore, the question was in which manner the two compounds interacts with 
the model membrane in order to obtain a better understanding of the 
mechanism of action.  
DPPC liposomes were prepared with increasing PS and PEA content and their 
size and size distribution was monitored. The results of the mean particle sizes 
are presented in Table 1 for the incorporation of phytosphingosine and for N-
palmitoylethanolamine in Table 2. As seen mean particle size of the liposomes 
and PDI-values increased with increasing concentration of PS and PEA 
suggesting that the molecules are adsorbing on the surface of the particles. 
 
Table 1 The effect of incorporation of phytosphingosine into DPPC liposomes 
on mean particle size, polydispersity index (PDI) and pH-values.  
 
Mol% PS Particle size (d.nm) PDI pH 
0  81 ± 6 0.24-0.25 6.3 ±0.2 
2,5                152 ± 7 0.29-0.41 8.4 ±0.0 
5 166 ±10 0.26-0.48 8.3 ±0.1 
10                178 ±7 0.34-0.50 8.6 ±0.0 
 
 
Table 2 The effect of N-palmitoylethanolamine into DPPC liposomes on mean 
particle size, polydispersity index (PDI) and pH-values 
 
Mol% PEA Particle size (d.nm) PDI pH 
    
0 81  ±6 0.24-0.25 6.3 ±0.2 
2,5 86  ±2 0.23-0.20 7.3 ±0.2 
5 90  ±4 0.26-0.33 7.5 ±0.0 
10 93  ±4 0.31-0.36 7.3 ±0.0 
 
Representative micro-DSC thermograms of DPPC liposomes containing various   
concentrations of PS and PEA are shown in Fig. 2 a-b. Furthermore effects of 
PS and PEA on pre- and main transition temperatures and enthalpies of 
reaction are presented in Table 3 and Table 4. The changes of the enthalpy are 
depicted in Fig. 3. 
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Table 3 Transition temperature and enthalpy values of DPPC liposomes 
containing phytosphingosine (PS).  
Mol % Tmax (°C)  Linear Onset (°C) Enthalpy (J/M) 
     
0 34.4 ±0.3 pre-transition 33.5 ±0.6 pre-transition 30          ±1    pre-transition 
0 41.4 ±0.1 main transition 40.1 ±0.1 main transition 30600    ±430main transition 
2,5 41.7 ±0.1  39.8 ±0.0 44000    ±2000 
5 41.8 ±0.0  40.3 ±0.3 40000    ±15000 
10 42.4 ±0.1   40.0 ±0.2 88000    ±16000 
 
Table 4 Transition temperature and enthalpy values of DPPC liposomes 
containing N-palmitoylethanolamine (PEA).   
Mol % Tmax (°C)  Linear Onset (°C) Enthalpy (J/M) 
     
0 34.4 ±0.3 pre-transition 33.5 ±0.6 pre-transition 30          ±1    pre-transition 
0 41.4 ±0.1main transition 40.1 ±0.1 main transition 30600    ±430main transition 
2,5 42.0 ±0.0  40.0 ±0.1 40700    ±1700 
5 42.0 ±0.2  40.2 ±0.8 45200    ±1080 
10 43.0 ±0.0  41.0 ±0.2 63000    ±2400 
 
Pure DPPC liposomes display the well-known sharp main transition near 41.4 
±0.05 °C, which belongs to the gel-to-liquid crystalline (Pß´?Lα) phase 
transition and a smaller pre-transition, which appears near 34.4 ±0.25°C 
reflecting the lamellar gel to rippled gel (Lß´ ?Pß´) transition in the gel phase. 
These data are in good agreement with literature values (Wolka et al 2004; 
Auner et al 2005; El Maghraby et al 2005; Krivanek et al 2008; Panicker 2008). 
The pre-transition have been generally attributed on the surface structure of the 
membrane and is related to rotations of the phospholipid head groups or 
transformation in the lamellar structure and changes in the hydrocarbon chain 
packing (Auner et al 2005). The main transition reflected the acyl chain 
“melting”, trans-gauche isomerisation took place in the acyl chain conformation 
of lipid molecules, effecting increasing the fluidity of the phospholipid bilayer 
(Wolka et al 2004; El Maghraby et al 2005). 
Incorporation of the two lipophilic compounds phytosphingosine (LogP 5.18) 
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and N-palmitoylethanolamine (LogP 5.82) are expected to preferentially 
partition into the lipid domains of the bilayer structure. The pre-transition 
disappeared with addition of PS and PEA for all tested concentrations          
(Fig. 2 a-b).  
 
 
 
 
     
 
 
 
 
 
 
 
  
a)      b) 
Fig. 2a-b Representative DSC scans of DPPC liposomes containing 0-10 mol% PS (a) and 0-10 
mol% PEA (b) 
 
The disappearance of the pre-transition suggests that the compounds 
interacted with the polar region of the phospholipid bilayer and interfered with 
the tilting of phospholipid acyl chains (Auner et al 2005; Panicker 2008). The 
main endotherm transition peak was increased with increasing molecular ratio 
of PS and PEA, respectively, and the peak becoming broader. The slight 
increase in the main transition peak suggests an interaction with the surface of 
the phospholipids. The results obtained could also be confirmed by 
measurements using ultrasonic velocity (data not shown). PS and PEA probably 
were able to fit into the bilayer with their head level with the head groups and 
the aliphatic chain parallel with the acyl chains of the phospholipid. Therefore, 
they were able to add bulkiness to the acyl chains and thus compensated for 
the bulkiness of the head groups. Thus chains will no longer tilt which can 
explain the absence of the pre-transition. This may add more structure to the 
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bilayer and can explain the increase Tm and the apparent increase in the 
enthalpy of the main transition seen in Fig. 3 (El Maghraby et al 2005). Main 
and pre-transition enthalpies in control liposomes were 30.7 KJ/mol and 0.03 
KJ/mol, respectively, which is in good agreement with literature data (Wolka et 
al 2004; Auner et al 2005). An additional transition was evident incorporating 
PEA into DPPC liposomes. The presence of two separate peaks suggests 
different modes of interaction of PEA with DPPC resulting in the formation of 
two-phase region of enhancer-phospholipid complex (Wolka et al 2004; 
Krivanek et al 2008).   
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Fig. 3 Effect of phytosphingosine (♦) and N-palmitoylethanolamine (■) on the transition 
enthalpies of DPPC liposomes.  
 
 
4. Conclusion 
 
The anti-inflammatory PS and PEA interacts with the lipid bilayers and induce 
variations in the temperature associated with the lipid main phase transition. 
Results indicate hydrophobic interactions in the liposome matrix and at the 
particle surface. Therefore, the observed effects on the model membrane may 
be part on the mechanism by which PS attenuate the hydrophobic properties of 
the stratum corneum lipids with the consequence increase in the skin diffusion. 
Consequently, the anti-inflammatory PS and PEA might be promising additives 
in drug delivery systems on skin.  
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5 Conclusion 
In the first part of this work changes in liquid crystalline microstructure of a 
transparent “ringing” gel have been investigated by incorporating different 
selected fluorinated drugs. The rheological properties and inner structure of 
cubic liquid crystal change hugely depended on temperature as well as on 
chemical structure of the model drug. Furthermore, the viscoelastic properties 
were dependent on the chemical structure of the drugs and can probably be 
related to the microstructure of the cubic system. Beside, the cubic gel showed 
excellent release profiles for the incorporated drugs promising a new candidate 
for drug delivery systems. Depending on the physiochemical properties of the 
drug, it may reside in the lipid bilayer or the aqueous channels of the gel and 
the location of the drug in the gel may influence its release [20]. However, also 
the mechanism by which cubic gels enhance the release and percutaneous 
absorption has to been taken into consideration. Therefore the combined effect 
of both the lipophilic and hydrophilic domains may be responsible for its 
enhancing activity over other common vehicles [55]. But not only the excellent 
vehicle properties of the cubic gel might be an advantage, also the high 
chemical stability of the incorporated drugs favour such colloidal systems as 
drug delivery vehicles. High chemical stability could be obtained over an 
observation period of 6 months (data shown for 10 weeks).    
In the second part of the work it was possible to create skin-compatible lecithin 
microemulsions. The phase behaviour of the microemulsions was influenced by 
the composition of the different soybean lecithins, particularly regarding the 
isotropic areas. The components phosphatidylethanolamine and 
lysophosphatidylcholine may be responsible for this probably by influencing the 
effective critical packing parameter in a different manner [23]. The biggest area 
achieved the microemulsion containing lipoid S75. Beside, the study 
demonstrated an impact on the release profiles of the model drug fluconazole 
using different commercially available soybean lecithins. The 
phosphatidylethanolamine content seems to play a major role in increasing the 
skin permeability, probably by inducing hydrophobic interactions between the 
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skin and the outwardly facing acyl chains of the inverted hexagonal phase 
adapted by PE [56].  
Moreover, the penetration enhancing effect of oleic acid and isopropyl myristate 
was analysed in different microemulsion systems. Oleic acid exhibited higher 
skin permeation profiles compared to IPM independent of the hydrophilicity of 
the lecithin based microemulsions. These results seem compatible with the 
main mechanism suggested for the action of oleic acid as a permeation 
enhancer increasing the fluidity of the skin lipids and therefore increasing 
stratum corneum permeability [47]. Additionally, it has been shown that oleic 
acid is more effective with highly hydrophilic compounds, which could be 
confirmed in our studies. The penetration enhancing effect of oleic acid was 
more pronounced in the hydrophilic microemulsion system.  
The insight in the physicochemical structure is of great importance to 
understand the complex interactions within the vehicle as well as between skin 
and vehicle. Therefore, in a next step the influence of different commercially 
available soybean lecithins on the microstructure of the colloidal systems could 
be demonstrated using different techniques. An increase of LPC, PE and LPE in 
the phospholipid mixtures increased the particle sizes and PDI. Moreover, a 
direct relationship between droplet size and NMR self-diffusion coefficients of 
the individual components within the different microemulsion systems could be 
demonstrated. The NMR self-diffusion coefficients indicated a bicontinuous 
structure. Furthermore, reasonable permeation of the incorporated lipophilic 
drugs of all microemulsions systems was confirmed in standard diffusion 
studies. This could be due to the incorporation of the drugs in the surfactant 
structure of the lecithin based bicontinous micro textures, as proven by 19F NMR 
self-diffusion studies.  
In the third part of this work we succeeded in creating nanoemulsions with the 
skin friendly mild surfactant sucrose laureate and polysorbate 80. The 
nanoemulsions exhibited a good stability, although the formulation with the 
conventional polyoxyethylene derivatives exhibited a prolonged 
physicochemical stability probably due to the steric stabilising effect. Moreover, 
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the good stability was due to the close droplet size distribution, preventing 
Ostwald ripening. In addition, the positive charge of the nanoemulsion particles, 
which was induced by phytosphingosine at physiological pH, was able to 
increase skin permeation of the tested model drug. However once again, the 
nanoemulsions containing polysorbate 80 exhibited higher skin permeation 
data. This could be due to the different penetration routes across skin of the 
different surfactants. Overall, PS is an interesting multifunctional additive for 
drug delivery systems due to its enhancement effect on skin permeation and 
above all its hydrating and anti-inflammatory power.  
In last part of this study liposomal membrane interaction studies were 
performed. Results indicate that phytosphingosine and N-palmitoylethanolamine 
undergoes hydrophobic and other types of interactions either in the liposome 
matrix or at the particle surface, or both, as indicated by changes in the pre- and 
main transition. Furthermore, phytosphingosine as well as N-
palmitoylethanolamine, destabilises both gel and liquid crystal phases within the 
DPPC bilayer as indicated by changes in the enthalpy.   
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